Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal acute lung injury (ALI) by driving hypercytokinemia and aggressive inflammation through mechanisms that remain elusive. In SARS-CoV/macaque models, we determined that anti–spike IgG (S-IgG), in productively infected lungs, causes severe ALI by skewing inflammation-resolving response. Alveolar macrophages underwent functional polarization in acutely infected macaques, demonstrating simultaneously both proinflammatory and wound-healing characteristics. The presence of S-IgG prior to viral clearance, however, abrogated wound-healing responses and promoted MCP1 and IL-8 production and proinflammatory monocyte/macrophage recruitment and accumulation. Critically, patients who eventually died of SARS (hereafter referred to as deceased patients) displayed similarly accumulated pulmonary proinflammatory, absence of wound-healing macrophages, and faster neutralizing antibody responses. Their sera enhanced SARS-CoV–induced MCP1 and IL-8 production by human monocyte–derived wound-healing macrophages, whereas blockade of FcγR reduced such effects. Our findings reveal a mechanism responsible for virus-mediated ALI, define a pathological consequence of viral specific antibody response, and provide a potential target for treatment of SARS-CoV or other virus-mediated lung injury.
Li Liu, Qiang Wei, Qingqing Lin, Jun Fang, Haibo Wang, Hauyee Kwok, Hangying Tang, Kenji Nishiura, Jie Peng, Zhiwu Tan, Tongjin Wu, Ka-Wai Cheung, Kwok-Hung Chan, Xavier Alvarez, Chuan Qin, Andrew Lackner, Stanley Perlman, Kwok-Yung Yuen, Zhiwei Chen
Title and authors | Publication | Year |
---|---|---|
Antibody-dependent enhancement of coronaviruses
Tao T, Tian L, Ke J, Zhang C, Li M, Xu X, Fan J, Tong Y, Fan H |
International Journal of Biological Sciences | 2025 |
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients.
Kaneko T, Ezra S, Abdo R, Voss C, Zhong S, Liu X, Hovey O, Slessarev M, Van Nynatten LR, Ye M, Fraser D, Li SS |
Clinical Proteomics | 2024 |
The laboratory parameters in predicting the severity and death of COVID-19 patients: Future pandemic readiness strategies
Alsayed AR, Ahmed SI, AL Shweiki AO, Al-Shajlawi M, Hakooz N |
2024 | |
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
Drury RE, Camara S, Chelysheva I, Bibi S, Sanders K, Felle S, Emary K, Phillips D, Voysey M, Ferreira DM, Klenerman P, Gilbert SC, Lambe T, Pollard AJ, O\u2019Connor D |
Nature Communications | 2024 |
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Dillard JA, Taft-Benz SA, Knight AC, Anderson EJ, Pressey KD, Parotti B, Martinez SA, Diaz JL, Sarkar S, Madden EA, De la Cruz G, Adams LE, Dinnon KH 3rd, Leist SR, Martinez DR, Schäfer A, Powers JM, Yount BL Jr, Castillo IN, Morales NL, Burdick J, Evangelista MKD, Ralph LM, Pankow NC, Linnertz CL, Lakshmanane P, Montgomery SA, Ferris MT, Baric RS, Baxter VK, Heise MT |
Nature Communications | 2024 |
Physicochemical properties-based hybrid machine learning technique for the prediction of SARS-CoV-2 T-cell epitopes as vaccine targets.
Bukhari SNH, Elshiekh E, Abbas M |
2024 | |
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R |
Human vaccines | 2024 |
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen
Ahuja R, Vishwakarma P, Raj S, Kumar V, Khatri R, Lohiya B, Saxena S, Kaur G, Singh G, Asthana S, Ahmed S, Samal S |
Human Vaccines & Immunotherapeutics | 2024 |
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model
Reed DS, McElroy AK, Barbeau DJ, McMillen CM, Tilston-Lunel NL, Nambulli S, Cottle E, Gilliland TC, Rannulu H, Lundy J, Olsen EL, O\u2019Malley KJ, Xia M, Hartman AL, Luke TC, Egland K, Bausch C, Wu H, Sullivan EJ, Klimstra WB, Duprex WP |
PloS one | 2024 |
Temporal Trends in SARS-CoV-2 Antibody Levels Among COVID-19 Patients in Kerala During the First Wave and Pre-vaccination Period
Mathew JK, Radhakrishnan C, K AB, Philomina BJ, K TN, Dhanasooraj D |
Cureus | 2024 |
Differentiating COVID-19 and influenza in children: hemogram parameters as diagnostic tools
Dulkadir R, Oztelcan Gunduz B |
Frontiers in public health | 2024 |
Mechanisms of antibody-dependent enhancement of infectious disease.
Wells TJ, Esposito T, Henderson IR, Labzin LI |
Nature reviews. Immunology | 2024 |
The Seraph 100® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients
Conner TL, Vir P, Laing ED, Stewart IJ, Mitre E, Pratt KP |
Antibodies | 2024 |
Pulmonary Injury as a Complication of Urinary Tract Infection in Pregnancy.
Hafez W, Al Shareef J, Alyoussef A, Ghanem M, Abazid RR, Yadav A, Rashid A, Sayfoo FM, Venkataramani S, Restrepo PO, Elkott MM, Lakshman VS, Arief T, Mohammed AG, Abdulaal F, Hossam Y |
International journal of MCH and AIDS | 2024 |
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine
Dashti N, Golsaz-Shirazi F, Soltanghoraee H, Zarnani AH, Mohammadi M, Imani D, Jeddi-Tehrani M, Amiri MM, Shokri F |
European Journal of Microbiology & Immunology | 2024 |
Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink
Boyce TG, McClure DL, Hanson KE, Daley MF, DeSilva MB, Irving SA, Jackson LA, Klein NP, Lewin B, Williams JT, Duffy J, McNeil MM, Weintraub ES, Belongia EA |
Pharmacoepidemiology and drug safety | 2024 |
Prediction of antigenic peptides of SARS- CoV-2 pathogen using machine learning
Bukhari SN, Ogudo KA |
PeerJ Computer Science | 2024 |
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages
Pickering S, Wilson H, Bravo E, Perera MR, Seow J, Graham C, Almeida N, Fotopoulos L, Williams T, Moitra A, Winstone H, Nissen TA, Galão RP, Snell LB, Doores KJ, Malim MH, Neil SJ |
Nature Communications | 2024 |
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibodies against SARS-CoV-2 and variants of concern
I-Jung Lee, Yu-Hua Lan, Ping-Yi Wu, Yan-Wei Wu, Yu-Hung Chen, Sheng-Che Tseng, Tzu- Kuo, Cheng-Pu Sun, Jia-Tsrong Jan, Hsiu-Hua Ma, Chun-Che Liao, Jian-Jong Liang, Hui- Ko, Chih-Shin Chang, Wen-Chun Liu, Yi-An Ko, Yen-Hui Chen, Zong-Lin Sie, Szu-I Tsung, Yi-Ling Lin, I-Hsuan Wang, Mi-Hua Tao |
Emerging Microbes & Infections | 2023 |
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2.
Luo M, Zhou B, Reddem ER, Tang B, Chen B, Zhou R, Liu H, Liu L, Katsamba PS, Au KK, Man HO, To KK, Yuen KY, Shapiro L, Dang S, Ho DD, Chen Z |
Emerging Microbes & Infections | 2023 |
Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-19
Monteiro FP, Tavares VD, Souza RD, Venâncio LP, Fabres-Klein MH, do Carmo RF, Klein RC, Lima JB, Araújo-Santos T |
Memórias do Instituto Oswaldo Cruz | 2023 |
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic
Kapten K, Orczyk K, Smolewska E |
Archivum Immunologiae et Therapiae Experimentalis | 2023 |
Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol
Liu Y |
Heliyon | 2023 |
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Tirelli C, De Amici M, Albrici C, Mira S, Nalesso G, Re B, Corsico AG, Mondoni M, Centanni S |
Biology | 2023 |
Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
Zekri L, Ruetalo N, Christie M, Walker C, Manz T, Rammensee HG, Salih HR, Schindler M, Jung G |
Frontiers in immunology | 2023 |
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets.
Martins M, do Nascimento GM, Conforti A, Noll JCG, Impellizeri JA, Sanchez E, Wagner B, Lione L, Salvatori E, Pinto E, Compagnone M, Viscount B, Hayward J, Shorrock C, Aurisicchio L, Diel DG |
Archives of Virology | 2023 |
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Liu M, Gan H, Liang Z, Liu L, Liu Q, Mai Y, Chen H, Lei B, Yu S, Chen H, Zheng P, Sun B |
Frontiers in microbiology | 2023 |
In vitro immunogenic profile of recombinant SARS-CoV2 S1-RBD peptide in murine macrophage and microglial cells
Chaves AJ Filho, Jucá PM, Soares MV, de Oliveira CA, de Sousa RC, Lós DB, Russo RC, Yaochite JN, Macedo DS |
Memórias do Instituto Oswaldo Cruz | 2023 |
SARS-CoV-2 infection and immune responses
Harne R, Williams B, Abdelal HF, Baldwin SL, Coler RN |
AIMS Microbiology | 2023 |
Non-neutralizing antibodies to SARS-Cov-2-related linear epitopes induce psychotic-like behavior in mice
Xu J, Wei H, You P, Sui J, Xiu J, Zhu W, Xu Q |
Frontiers in molecular neuroscience | 2023 |
Immunology of SARS-CoV-2 infection and vaccination
Lin B, Cheng L, Zhang J, Yang M, Zhang Y, Liu J, Qin X |
Clinica chimica acta; international journal of clinical chemistry | 2023 |
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen J, Fan J, Zhao Y, Jiang D, Niu Z, Zhang Z, Cao G |
Frontiers in immunology | 2023 |
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
Li S, Wu X, Li N, Cao G, Wang J, Chen Y, Li S, He J, Wu J, Yang H, Lin K, Qiu C, Liu A, Zhou H, Adrian F, Schweizer L, Zhang W, Gu J, Zhang J |
Frontiers in pharmacology | 2023 |
Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice
Wen Z, Yuan Y, Zhao Y, Wang H, Han Z, Li M, Yuan J, Sun C |
Viruses | 2023 |
Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19
Matveev A, Pyankov O, Khlusevich Y, Tyazhelkova O, Emelyanova L, Timofeeva A, Shipovalov A, Chechushkov A, Zaitseva N, Kudrov G, Yusubalieva G, Yussubaliyeva S, Zhukova O, Baklaushev V, Sedykh S, Lifshits G, Tikunov A, Tikunova N |
International journal of molecular sciences | 2023 |
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
de Moor WR, Williamson AL, Schäfer G, Douglass N, Gers S, Sutherland AD, Blumenthal MJ, Margolin E, Shaw ML, Preiser W, Chapman R |
Viruses | 2023 |
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
Ziganshina MM, Shilova NV, Khalturina EO, Dolgushina NV, V. Borisevich S, Yarotskaya EL, Bovin NV, Sukhikh GT |
Viruses | 2023 |
SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1
Zhou B, Zhou R, Chan JF, Zeng J, Zhang Q, Yuan S, Liu L, Robinot R, Shan S, Liu N, Ge J, Kwong HY, Zhou D, Xu H, Chan CC, Poon VK, Chu H, Yue M, Kwan KY, Chan CY, Chan CC, Chik KK, Du Z, Au KK, Huang H, Man HO, Cao J, Li C, Wang Z, Zhou J, Song Y, Yeung ML, To KK, Ho DD, Chakrabarti LA, Wang X, Zhang L, Yuen KY, Chen Z |
Emerging Microbes & Infections | 2023 |
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')(2) fragments.
Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Aldridge M, Humphries G, Schuhmann H, Ngabo D, Rayner E, Otter A, Coleman T, Hicks B, Halkerston R, Apostolakis K, Taylor S, Fotheringham S, Horton A, CanoCejas I, Wand M, Tree JA, Sutton M, Graham V, Hewson R, Dowall S |
Scientific Reports | 2023 |
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
Geyer CE, Chen HJ, Bye AP, Manz XD, Guerra D, Caniels TG, Bijl TP, Griffith GR, Hoepel W, de Taeye SW, Veth J, Vlaar AP, Vidarsson G, Bogaard HJ, Aman J, Gibbins JM, van Gils MJ, de Winther MP, den Dunnen J |
Life science alliance | 2023 |
Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies
Almeida NB, Fantone KM, Sarr D, Ashtiwi NM, Channell S, Grenfell RF, Martins-Filho OA, Rada B |
Frontiers in immunology | 2023 |
An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection
Mei X, Li J, Wang Z, Zhu D, Huang K, Hu S, Popowski KD, Cheng K |
Nature Materials | 2023 |
Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
Yang H, Xie Y, Lu S, Sun Y, Wang K, Li S, Wang J, Liao G, Li C |
Human vaccines | 2023 |
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
Sun CP, Chiu CW, Wu PY, Tsung SI, Lee IJ, Hu CW, Hsu MF, Kuo TJ, Lan YH, Chen LY, Ng HY, Chung MJ, Liao HN, Tseng SC, Lo CH, Chen YJ, Liao CC, Chang CS, Liang JJ, Draczkowski P, Puri S, Chang YC, Huang JS, Chen CC, Kau JH, Chen YH, Liu WC, Wu HC, Danny Hsu ST, Wang IH, Tao MH |
Molecular Therapy | 2023 |
PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis
Bai X, Chen T, Li Y, Ge X, Qiu C, Gou H, Wei S, Liu T, Yang W, Yang L, Liang Y, Jia Z, Lv L, Li T |
Stem Cell Research & Therapy | 2023 |
SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
Wang YC, Tsai CH, Wang YC, Yen LC, Chang YW, Sun JR, Lin TY, Chiu CH, Chao YC, Chang FY |
Infection | 2023 |
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.
Cross RW, Wiethoff CM, Brown-Augsburger P, Berens S, Blackbourne J, Liu L, Wu X, Tetreault J, Dodd C, Sina R, Witcher DR, Newcomb D, Frost D, Wilcox A, Borisevich V, Agans KN, Woolsey C, Prasad AN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Strifler B, Ebert P, Higgs R, Beall A, Chanda S, Riva L, Yin X, Geisbert TW |
2023 | |
Mitochondria regulate extrafollicular B cell responses to reduce COVID-19 severity
Tianyu Cao, Li Liu, Kelvin To, Chun-Yu Lim, Runhong Zhou, Hallie Kwan, Ming Yue, Sulan Yu, Chun-Yin Chan, Biao Zhou, Haode Huang, Yufei Mo, Zhenglong Du, Ruomei Gong, Luk-Tsz Yat, Ivan Fan-Ngai Hung, Anthony Raymond Tam, Wing-Kin To, Wai-Shing Leung, Thomas Shiu-Hong Chik, Owen Tak-Yin Tsang, Xiang Lin, You-qiang Song, K.Y. Yuen, Zhiwei Chen |
Clinical and Translational Medicine | 2022 |
JMJD3 is required for acute pancreatitis and pancreatitis-associated lung injury
Li Chen, Xiangxian Zhang, Yu Liu, Li Liu, Xiao Liang, Shengqun Yang, Qing Xia, Tao Jin, Yun Ma, Yonghua Chen, Xia Yuan, Yan Tie, Yangzhuo Gu, Chunju Fang, Siyuan Chen, Fei Mo, Ting Yu, Yuzhu Hu, Zhiyong Qian, Yong Peng, Jia Geng, Zongguang Zhou, Min Wu, Jiansheng Ding, Daoke Yang, Xiawei Wei |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
R Zhou, P Wang, YC Wong, H Xu, SY Lau, L Liu, BW Mok, Q Peng, N Liu, KF Woo, S Deng, RC Tam, H Huang, AJ Zhang, D Zhou, B Zhou, CY Chan, Z Du, D Yang, KK Au, KY Yuen, H Chen, Z Chen |
EBioMedicine | 2022 |
NETosis and SARS-COV-2 infection related thrombosis: a narrative review
M Behzadifard, M Soleimani |
Thrombosis Journal | 2022 |
Adaptive MHC-E restricted tissue-resident NK cells are associated with persistent low antigen load in alveolar macrophages after SARS-CoV-2 infection
Nicolas Huot, Cyril Planchais, Vanessa Contreras, Beatrice Jacquelin, Caroline Petitdemange, Marie Lazzerini, Pierre Rosenbaum, Félix Rey, R Keith Reeves, Roger Le Grand, Hugo Mouquet, Michaela Müller-Trutwin |
Research square | 2022 |
The role of antigen-presenting cells in the pathogenesis of COVID-19
R Farzi, P Aghbash, N Eslami, A Azadi, A Shamekh, N Hemmat, T Entezari-Maleki, H Baghi |
Pathology, research and practice | 2022 |
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko, FY Ke, KH Liang, TY Hsieh, HC Wu |
Journal of Biomedical Science | 2022 |
COVID-19 infection: an overview on cytokine storm and related interventions
S Montazersaheb, S Khatibi, M Hejazi, V Tarhriz, A Farjami, F Sorbeni, R Farahzadi, T Ghasemnejad |
Virology Journal | 2022 |
The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19
G Xu, F Qi, H Wang, Y Liu, X Wang, R Zou, J Yuan, X Liao, Y Liu, S Zhang, Z Zhang |
Frontiers in immunology | 2022 |
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
A Shafqat, S Shafqat, S Salameh, J Kashir, K Alkattan, A Yaqinuddin |
Frontiers in immunology | 2022 |
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
S Ajmeriya, A Kumar, S Karmakar, S Rana, H Singh |
JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE | 2022 |
Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19
J Park, M Cha, H Choi, M Kim, J Chung, K Lee, D Jeong, M Baek, W Kim, Y Lim, S Yoon, S Choi |
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2022 |
The T cell immune response against SARS-CoV-2
P Moss |
Nature Immunology | 2022 |
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
Q Peng, R Zhou, Y Wang, M Zhao, N Liu, S Li, H Huang, D Yang, K Au, H Wang, K Man, K Yuen, Z Chen |
EBioMedicine | 2022 |
COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines
G Malcangi, A Inchingolo, A Inchingolo, F Piras, V Settanni, G Garofoli, G Palmieri, S Ceci, A Patano, A Mancini, L Vimercati, D Nemore, A Scardapane, B Rapone, A Semjonova, M DOria, L Macchia, I Bordea, G Migliore, A Scarano, F Lorusso, G Tartaglia, D Giovanniello, L Nucci, N Maggialetti, A Parisi, M Domenico, N Brienza, S Tafuri, P Stefanizzi, L Curatoli, A Corriero, M Contaldo, F Inchingolo, G Dipalma |
Children | 2022 |
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.
He Q, Mao Q, Peng X, He Z, Lu S, Zhang J, Gao F, Bian L, An C, Yu W, Yang F, Zhou Y, Yang Y, Li Y, Yuan Y, Yan X, Yang J, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M |
Signal Transduction and Targeted Therapy | 2022 |
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
Chakraborty C, Sharma AR, Bhattacharya M, Lee SS |
Frontiers in immunology | 2022 |
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes
Garrido JL, Medina MA, Bravo F, McGee S, Fuentes-Villalobos F, Calvo M, Pinos Y, Bowman JW, Bahl CD, Barria MI, Brachman RA, Alvarez RA |
Cell Reports | 2022 |
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
Kovalenko AO, Ryabchevskaya EM, Evtushenko EA, Manukhova TI, Kondakova OA, Ivanov PA, Arkhipenko MV, Gushchin VA, Nikitin NA, Karpova OV |
Frontiers in microbiology | 2022 |
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge.
Zhou B, Zhou R, Tang B, Chan JF, Luo M, Peng Q, Yuan S, Liu H, Mok BW, Chen B, Wang P, Poon VK, Chu H, Chan CC, Tsang JO, Chan CC, Au KK, Man HO, Lu L, To KK, Chen H, Yuen KY, Dang S, Chen Z |
Nature Communications | 2022 |
Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
Bellanti F, Lo Buglio A, Vendemiale G |
Biology | 2022 |
Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction
Wang S, Wang J, Yu X, Jiang W, Chen S, Wang R, Wang M, Jiao S, Yang Y, Wang W, Chen H, Chen B, Gu C, Liu C, Wang A, Wang M, Li G, Guo C, Liu D, Zhang J, Zhang M, Wang L, Gui X |
2022 | |
COVID-19 Vaccine: Between Myth and Truth
Piccaluga PP, Di Guardo A, Lagni A, Lotti V, Diani E, Navari M, Gibellini D |
Human vaccines | 2022 |
Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
Mooij P, García-Arriaza J, Pérez P, Lázaro-Frías A, Verstrepen BE, Böszörményi KP, Mortier D, Fagrouch Z, Kiemenyi-Kayere G, Niphuis H, Acar RF, Meijer L, Stammes MA, Kondova I, Verschoor EJ, GeurtsvanKessel CH, de Bruin E, Sikkema RS, Luczkowiak J, Delgado R, Montenegro D, Puentes E, Rodríguez E, Bogers WM, Koopman G, Esteban M |
Frontiers in immunology | 2022 |
MutCov: A pipeline for evaluating the effect of mutations in spike protein on infectivity and antigenicity of SARS-CoV-2
Zhou W, Xu C, Luo M, Wang P, Xu Z, Xue G, Jin X, Huang Y, Li Y, Nie H, Jiang Q, Anashkina AA |
Computers in Biology and Medicine | 2022 |
Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro
Luan N, Li T, Wang Y, Cao H, Yin X, Lin K, Liu C |
Frontiers in immunology | 2022 |
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhang Z, Shen Q, Chang H |
Frontiers in immunology | 2022 |
A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model
Fovet CM, Pimienta C, Galhaut M, Relouzat F, Nunez N, Cavarelli M, Sconosciuti Q, Dhooge N, Marzinotto I, Lampasona V, Tolazzi M, Scarlatti G, Ho Tsong Fang R, Naninck T, Dereuddre-Bosquet N, Van Wassenhove J, Gallouët AS, Maisonnasse P, Le Grand R, Menu E, Seddiki N |
Frontiers in immunology | 2022 |
Is COVID-19 really a geriatric syndrome?
Akbarzadeh MA, Hosseini MS |
Ageing Research Reviews | 2022 |
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis
Batu ED, Sener S, Ozen S |
Seminars in Arthritis and Rheumatism | 2022 |
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Upreti S, Samant M |
Pharmaceutical Research | 2022 |
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine
Lin YJ, Lin MY, Chuang YS, Liu LT, Kuo TY, Chen C, Ganesan S, Fattom A, Bitko V, Lien CE |
Scientific Reports | 2022 |
Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
Li M, Liu J, Lu R, Zhang Y, Du M, Xing M, Wu Z, Kong X, Zhu Y, Zhou X, Hu L, Zhang C, Zhou D, Jin X |
Journal of Allergy and Clinical Immunology | 2022 |
Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital:A Cross-sectional Study.
Talwar D, Kumar S, Acharya S, Raisinghani N, Madaan S, Hulkoti V, Akhilesh A, Khanna S, Shah D, Nimkar S |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2022 |
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2.
Foix A, López D, Díez-Fuertes F, McConnell MJ, Martín-Galiano AJ |
PLoS computational biology | 2022 |
A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.
Shahbaz FF, Martins RS, Umair A, Ukrani RD, Jabeen K, Sohail MR, Khan E |
Clinical Medicine Insights Pediatrics | 2022 |
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
Clark NM, Janaka SK, Hartman W, Stramer S, Goodhue E, Weiss J, Evans DT, Connor JP |
PloS one | 2022 |
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.
Gartlan C, Tipton T, Salguero FJ, Sattentau Q, Gorringe A, Carroll MW |
Frontiers in immunology | 2022 |
Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.
Sepand MR, Bigdelou B, Ho JQ, Sharaf M, Lannigan AJ, Sullivan IM, da Silva AP, Barrett LO, McGoldrick S, Lnu Y, Lynch SE, Boisclair JM, Barnard-Pratt DD, Zanganeh S |
2022 | |
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE |
Immunological Reviews | 2022 |
A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine
Adam A, Shi Q, Wang B, Zou J, Mai J, Osman SR, Wu W, Xie X, Aguilar PV, Bao X, Shi PY, Shen H, Wang T |
Translational Research | 2022 |
Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series
More K, Aiyer S, Goti A, Parikh M, Sheikh S, Patel G, Kallem V, Soni R, Kumar P |
European Journal of Pediatrics | 2022 |
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19
Kritikos A, Gabellon S, Pagani JL, Monti M, Bochud PY, Manuel O, Coste A, Greub G, Perreau M, Pantaleo G, Croxatto A, Lamoth F |
Viruses | 2022 |
Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Zanella I, Degli Antoni M, Marchese V, Castelli F, Quiros-Roldan E |
International Immunopharmacology | 2022 |
Advances in nanotechnology application in biosafety materials: A crucial response to COVID-19 pandemic
Morajkar RV, Kumar AS, Kunkalekar RK, Vernekar AA |
2022 | |
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Wang Z, Li S, Huang B |
Signal Transduction and Targeted Therapy | 2022 |
Post-COVID-19 HSV encephalitis: a review.
Gupta S, Dutta A, Chakraborty U, Kumar R, Das D, Ray BK |
QJM : monthly journal of the Association of Physicians | 2022 |
Antibody-mediated immunity to SARS-CoV-2 spike
Errico JM, Adams LJ, Fremont DH |
Advances in immunology | 2022 |
Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Bigay J, Le Grand R, Martinon F, Maisonnasse P |
Frontiers in microbiology | 2022 |
Host and microbiome features of secondary infections in lethal covid-19.
Zacharias M, Kashofer K, Wurm P, Regitnig P, Schütte M, Neger M, Ehmann S, Marsh LM, Kwapiszewska G, Loibner M, Birnhuber A, Leitner E, Thüringer A, Winter E, Sauer S, Pollheimer MJ, Vagena FR, Lackner C, Jelusic B, Ogilvie L, Durdevic M, Timmermann B, Lehrach H, Zatloukal K, Gorkiewicz G |
iScience | 2022 |
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
He Q, Mao Q, Zhang J, Gao F, Bai Y, Cui B, Liu J, An C, Wang Q, Yan X, Yang J, Song L, Song Z, Liu D, Yuan Y, Sun J, Zhao J, Bian L, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M |
Frontiers in immunology | 2022 |
Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants
Chen CP, Huang KY, Shih SR, Lin YC, Cheng CY, Huang YC, Lin TY, Cheng SH |
Microbiology spectrum | 2022 |
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza
Merigeon EY, Yang D, Ihms EA, Bassit LC, Fitzpatrick EA, Jonsson CB, Schinazi RF, Block DS, Olsen HS |
Pathogens and Immunity | 2022 |
The role of B cells in COVID-19 infection and vaccination
Chen S, Guan F, Candotti F, Benlagha K, Camara NO, Herrada AA, James LK, Lei J, Miller H, Kubo M, Ning Q, Liu C |
Frontiers in immunology | 2022 |
Focus on long non-coding RNA MALAT1: Insights into acute and chronic lung diseases
Lai X, Zhong J, Zhang A, Zhang B, Zhu T, Liao R |
Frontiers in Genetics | 2022 |
Vaccines platforms and COVID-19: what you need to know
Acosta-Coley I, Cervantes-Ceballos L, Tejeda-Benítez L, Sierra-Márquez L, Cabarcas-Montalvo M, García-Espiñeira M, Coronell-Rodríguez W, Arroyo-Salgado B |
Tropical Diseases, Travel Medicine and Vaccines | 2022 |
Broad‐spectrum antiviral activity of Spatholobus suberectus Dunn against SARS‐CoV‐2, SARS‐CoV‐1, H5N1, and other enveloped viruses
Liu Q, Kwan K, Cao T, Yan B, Ganesan K, Jia L, Zhang F, Lim C, Wu Y, Feng Y, Chen Z, Liu L, Chen J |
Phytotherapy Research | 2022 |
SARS‐CoV‐2 vaccines: A double‐edged sword throughout rapid evolution of COVID‐19
Zolfaghari MA, Ghadiri Moghaddam F, Rajput S, Karimi A, Naghi Vishteh M, Mahmoodpoor A, Dolati S, Yousefi M |
Cell biology international | 2022 |
Highly pathogenic coronaviruses and the kidney
Wang F, Suo XG, Wang C, Wang JN, He XY, Wang FC, Jin J, Wen JG, Ni WJ, Shen BX, Meng XM |
Biomedicine & Pharmacotherapy | 2022 |
Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2
Peng Q, Zhou R, Liu N, Wang H, Xu H, Zhao M, Yang D, Au KK, Huang H, Liu L, Chen Z |
Cellular and Molecular Immunology | 2022 |
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level.
Demoliou C, Papaneophytou C, Nicolaidou V |
International journal of medical sciences | 2022 |
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
Ganesan S, Acosta H, Brigolin C, Orange K, Trabbic K, Chen C, Lien CE, Lin YJ, Lin MY, Chuang YS, Fattom A, Bitko V |
PloS one | 2022 |
Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine
Gong HR, Hu YF, Li X, Yau T, Zhang BZ, Huang JD |
ACS Infectious Diseases | 2022 |
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections.
Goh YS, Fong SW, Hor PX, Amrun SN, Lee CY, Young BE, Chia PY, Tambyah PA, Kalimuddin S, Pada S, Tan SY, Sun LJ, Chen MI, Leo YS, Lye DC, Ng LFP, Renia L |
Frontiers in microbiology | 2022 |
SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry.
Matveeva O, Nechipurenko Y, Lagutkin D, Yegorov YE, Kzhyshkowska J |
Frontiers in immunology | 2022 |
The frequency and seasonal distribution of viral infection in patients with community-acquired pneumonia and its impact on the prognosis
Kim KJ, Kim DH |
2022 | |
Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?
Talotta R |
Microorganisms | 2022 |
Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content
Han L, An C, Liu D, Wang Z, Bian L, He Q, Liu J, Wang Q, Liu M, Mao Q, Hang T, Wang A, Gao F, Tan D, Liang Z |
Viruses | 2022 |
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022
Caroline Atyeo, Matthew D. Slein, Stephanie Fischinger, John S. Burke, Alexandra Schafer, Sarah R. Leist, Natalia A. Kuzmina, Chad E. Mire, Anna Honko, Rebecca I. Johnson, Nadia Storm, Matthew J. Bernett, Pei Tong, Teng Zuo, Junrui Lin, Adam Zuiani, Caitlyn H. Linde, Todd J. Suscovich, Duane R. Wesemann, Anthony Griffiths, John R. Desjarlais, Boris D. Julg, Jaap Goudsmit, Alexander Bukreyev, Ralph Baric, Galit Alter |
JCI Insight | 2021 |
Natural Mucosal Barriers and COVID-19 in Children
Carl A. Pierce, Sharlene Sy, Benjamin Galen, Doctor Y Goldstein, Erika P Orner, Marla J. Keller, Kevan C Herold, Betsy Herold |
JCI Insight | 2021 |
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus
Ami Patel, Emma L. Reuschel, Ziyang Xu, Faraz I. Zaidi, Kevin Y. Kim, Dana Scott, Janess Mendoza, Stephanie Ramos, Regina Stoltz, Friederike Feldmann, Atsushi Okumura, Kimberly Meade-White, Elaine Haddock, Tina Thomas, Rebecca Rosenke, Jamie Lovaglio, Patrick W Hanley, Greg Saturday, Kar Muthumani, Heinz Feldmann, Laurent Humeau, Kate Broderick, David B Weiner |
JCI Insight | 2021 |
Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
JL Yates, DJ Ehrbar, DT Hunt, RC Girardin, AP Dupuis, AF Payne, M Sowizral, S Varney, KE Kulas, VL Demarest, KM Howard, K Carson, M Hales, M Ejemel, Q Li, Y Wang, R Peredo-Wende, A Ramani, G Singh, K Strle, NJ Mantis, KA McDonough, WT Lee |
Reproduction | 2021 |
High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2
B Vanhove, O Duvaux, J Rousse, PJ Royer, G Evanno, C Ciron, E Lheriteau, L Vacher, N Gervois, R Oger, Y Jacques, S Conchon, A Salama, R Duchi, I Lagutina, A Perota, P Delahaut, M Ledure, M Paulus, RT So, CK Mok, R Bruzzone, M Bouillet, S Brouard, E Cozzi, C Galli, D Blanchard, JM Bach, JP Soulillou |
European Journal of Immunology | 2021 |
Combining Antivirals and Immunomodulators to Fight COVID-19
V Feuillet, B Canard, A Trautmann |
Trends in Immunology | 2021 |
Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
CE Geyer, L Mes, M Newling, J den Dunnen, W Hoepel |
Cells | 2021 |
Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease
IO Awogbindin, B Ben-Azu, BA Olusola, ET Akinluyi, PA Adeniyi, TD Paolo, MÈ Tremblay |
Frontiers in cellular neuroscience | 2021 |
COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies
G Malcangi, AD Inchingolo, AM Inchingolo, L Santacroce, G Marinelli, A Mancini, L Vimercati, ME Maggiore, MT DOria, D Hazballa, IR Bordea, E Xhajanka, A Scarano, M Farronato, GM Tartaglia, D Giovanniello, L Nucci, R Serpico, G Sammartino, L Capozzi, A Parisi, MD Domenico, F Lorusso, M Contaldo, F Inchingolo, G Dipalma |
Microorganisms | 2021 |
Pathogenesis of Respiratory Viral and Fungal Coinfections
F Salazar, E Bignell, GD Brown, PC Cook, A Warris |
Clinical microbiology reviews | 2021 |
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
W Zhan, M Muhuri, PW Tai, G Gao |
Frontiers in immunology | 2021 |
An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi, M Sanaei, M Namvarpour, R Eftekhari |
International Immunopharmacology | 2021 |
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
VJ Venditto, D Haydar, A Abdel-Latif, JC Gensel, MI Anstead, MG Pitts, J Creameans, TJ Kopper, C Peng, DJ Feola |
Frontiers in immunology | 2021 |
COVID-19: Immunology, Immunopathogenesis and Potential Therapies
A Bhardwaj, L Sapra, C Saini, Z Azam, PK Mishra, B Verma, GC Mishra, RK Srivastava |
International Reviews of Immunology | 2021 |
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
LY Wong, S Perlman |
Nature Reviews Immunology | 2021 |
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages
W Hoepel, HJ Chen, CE Geyer, S Allahverdiyeva, XD Manz, SW de Taeye, J Aman, L Mes, M Steenhuis, GR Griffith, PI Bonta, PJ Brouwer, TG Caniels, K van der Straten, K Golebski, RE Jonkers, MD Larsen, F Linty, J Nouta, CP van Roomen, FE van Baarle, CM van Drunen, G Wolbink, AP Vlaar, GJ de Bree, RW Sanders, L Willemsen, AE Neele, D van de Beek, T Rispens, M Wuhrer, HJ Bogaard, MJ van Gils, G Vidarsson, M de Winther, J den Dunnen |
Science Translational Medicine | 2021 |
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
MD Larsen, EL de Graaf, ME Sonneveld, HR Plomp, J Nouta, W Hoepel, HJ Chen, F Linty, R Visser, M Brinkhaus, T Šuštić, SW de Taeye, AE Bentlage, S Toivonen, CA Koeleman, S Sainio, NA Kootstra, PJ Brouwer, CE Geyer, NI Derksen, G Wolbink, M de Winther, RW Sanders, MJ van Gils, S de Bruin, AP Vlaar, T Rispens, J den Dunnen, HL Zaaijer, M Wuhrer, CE van der Schoot, G Vidarsson, M van Agtmael, AG Algera, F van Baarle, D Bax, D van de Beek, M Beudel, HJ Bogaard, PI Bonta, M Bomers, L Bos, M Botta, G de Bree, MC Brouwer, J Brabander, S de Bruin, M Bugiani, E Bulle, O Chouchane, A Cloherty, P Elbers, L Fleuren, S Geerlings, B Geerts, T Geijtenbeek, A Girbes, B Goorhuis, MP Grobusch, F Hafkamp, L Hagens, J Hamann, V Harris, R Hemke, SM Hermans, L Heunks, MW Hollmann, J Horn, JW Hovius, M de Jong, R Koning, N van Mourik, J Nellen, EJ Nossent, F Paulus, E Peters, T van der Poll, B Preckel, JM Prins, J Raasveld, T Rijnders, M Schinkel, M Schultz, AR Schuurmans, K Sigaloff, M Smit, CS Stijnis, W Stilma, C Teunissen, P Thoral, A Tsonas, M van der Valk, D Veelo, AP Vlaar, H de Vries, M van Vugt, WJ Wiersinga, D Wouters, AH Zwinderman |
Science | 2021 |
Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
F Bohländer, D Riehl, S Weißmüller, M Gutscher, J Schüttrumpf, S Faust |
Frontiers in immunology | 2021 |
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
A MarcosJiménez, S SánchezAlonso, A AlcarazSerna, L Esparcia, C LópezSanz, M SampedroNúñez, T MateuAlbero, I SánchezCerrillo, P MartínezFleta, L Gabrie, LC Guerola, JM RodríguezFrade, JM Casasnovas, HT Reyburn, M ValésGómez, M LópezTrascasa, E MartínGayo, MJ Calzada, S Castañeda, H Fuente, I GonzálezÁlvaro, F SánchezMadrid, C MuñozCalleja, A Alfranca |
European Journal of Immunology | 2021 |
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
A Hasan, E Al-Ozairi, Z Al-Baqsumi, R Ahmad, F Al-Mulla |
ImmunoTargets and Therapy | 2021 |
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
CJ Batty, MT Heise, EM Bachelder, KM Ainslie |
Advanced Drug Delivery Reviews | 2021 |
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
SP Keeler, JM Fox |
Viruses | 2021 |
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
N Beeraka, S Tulimilli, M Karnik, S Sadhu, R Pragada, G Aliev, S Madhunapantula, J Lu |
BioMed Research International | 2021 |
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
B Alosaimi, A Mubarak, ME Hamed, AZ Almutairi, AA Alrashed, A AlJuryyan, M Enani, FQ Alenzi, W Alturaiki |
Frontiers in immunology | 2021 |
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
KJ Selva, CE van de Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, SK Davis, TH Nguyen, LC Rowntree, L Hensen, M Koutsakos, CY Wong, F Mordant, DC Jackson, KL Flanagan, J Crowe, S Tosif, MR Neeland, P Sutton, PV Licciardi, NW Crawford, AC Cheng, DL Doolan, F Amanat, F Krammer, K Chappell, N Modhiran, D Watterson, P Young, WS Lee, BD Wines, PM Hogarth, R Esterbauer, HG Kelly, HX Tan, JA Juno, AK Wheatley, SJ Kent, KB Arnold, K Kedzierska, AW Chung |
Nature Communications | 2021 |
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
JL Boechat, I Chora, A Morais, L Delgado |
2021 | |
Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine
X He, W Hong, J Yang, H Lei, T Lu, C He, Z Bi, X Pan, Y Liu, L Dai, W Wang, C Huang, H Deng, X Wei |
Signal Transduction and Targeted Therapy | 2021 |
Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study
V Opoka-Winiarska, E Grywalska, I Korona-Glowniak, K Matuska, A Malm, J Roliński |
Journal of Clinical Medicine | 2021 |
Immune dysregulation and system pathology in COVID-19
M Jamal, HI Bangash, M Habiba, Y Lei, T Xie, J Sun, Z Wei, Z Hong, L Shao, Q Zhang |
Virulence | 2021 |
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
RA Grant, L Morales-Nebreda, NS Markov, S Swaminathan, M Querrey, ER Guzman, DA Abbott, HK Donnelly, A Donayre, IA Goldberg, ZM Klug, N Borkowski, Z Lu, H Kihshen, Y Politanska, L Sichizya, M Kang, A Shilatifard, C Qi, JW Lomasney, AC Argento, JM Kruser, ES Malsin, CO Pickens, SB Smith, JM Walter, AE Pawlowski, D Schneider, P Nannapaneni, H Abdala-Valencia, A Bharat, CJ Gottardi, GR Budinger, AV Misharin, BD Singer, RG Wunderink |
Nature | 2021 |
Immunological Approaches to the Treatment of Novel Coronavirus Infection (Review)
NA Lyubavina, SG Saltsev, NV Menkov, LV Tyurikova, SS Plastinina, ML Shonia, AA Tulichev, MY Milyutina, EV Makarova |
2021 | |
SARS-CoV-2: vaccines in the pandemic era
DD Li, QH Li |
Military Medical Research | 2021 |
A look-back at convalescent plasma to treat COVID-19
O Garraud, K Lacombe, P Tiberghien |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
F Bertoglio, D Meier, N Langreder, S Steinke, U Rand, L Simonelli, PA Heine, R Ballmann, KT Schneider, KD Roth, M Ruschig, P Riese, K Eschke, Y Kim, D Schäckermann, M Pedotti, P Kuhn, S Zock-Emmenthal, J Wöhrle, N Kilb, T Herz, M Becker, M Grasshoff, EV Wenzel, G Russo, A Kröger, L Brunotte, S Ludwig, V Fühner, SD Krämer, S Dübel, L Varani, G Roth, L Čičin-Šain, M Schubert, M Hust |
Nature Communications | 2021 |
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
MS Winkler, T Skirecki, FM Brunkhorst, S Cajander, JM Cavaillon, R Ferrer, SB Flohé, A García-Salido, EJ Giamarellos-Bourboulis, M Girardis, M Kox, G Lachmann, I Martin-Loeches, MG Netea, T Spinetti, JC Schefold, A Torres, F Uhle, F Venet, S Weis, A Scherag, I Rubio, MF Osuchowski |
EBioMedicine | 2021 |
Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
P Wang, SY Lau, S Deng, P Chen, BW Mok, AJ Zhang, AC Lee, KH Chan, RC Tam, H Xu, R Zhou, W Song, L Liu, KK To, JF Chan, Z Chen, KY Yuen, H Chen |
Nature Communications | 2021 |
Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers
E Knyazev, S Nersisyan, A Tonevitsky |
Frontiers in immunology | 2021 |
COVID-19: inflammatory responses, structure-based drug design and potential therapeutics
N Tripathi, N Tripathi, MK Goshisht |
Molecular Diversity | 2021 |
Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?
W Conca, M Alabdely, F Albaiz, MW Foster, M Alamri, M Alkaff, F Al-Mohanna, N Nagelkerke, RS Almaghrabi, C Lazzeri |
PloS one | 2021 |
The conundrum of current anti-SARS-CoV-2 vaccines
M Federico |
Cytokine & Growth Factor Reviews | 2021 |
Monocytes and Macrophages in COVID-19
R Knoll, JL Schultze, J Schulte-Schrepping |
Frontiers in immunology | 2021 |
Highly active engineered IgG3 antibodies against SARS-CoV-2
S Kallolimath, L Sun, R Palt, K Stiasny, P Mayrhofer, C Gruber, B Kogelmann, Q Chen, H Steinkellner |
Proceedings of the National Academy of Sciences | 2021 |
COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire
N Seddiki, M French |
Frontiers in immunology | 2021 |
Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
J Hong, H Jhun, YO Choi, AS Taitt, S Bae, Y Lee, C Song, SC Yeom, S Kim |
Immune Network | 2021 |
A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage
F Gambino, W Tai, D Voronin, Y Zhang, X Zhang, J Shi, X Wang, N Wang, L Du, L Qiao |
Cell Reports | 2021 |
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari, F Noorbakhsh |
International Immunopharmacology | 2021 |
Putative Role of Vitamin D for COVID-19 Vaccination
SK Chiu, KW Tsai, CC Wu, CM Zheng, CH Yang, WC Hu, YC Hou, KC Lu, YC Chao |
International journal of molecular sciences | 2021 |
A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy
PK Devarasetti, L Rajasekhar, R Baisya, KS Sreejitha, YK Vardhan |
Immunologic Research | 2021 |
Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2
BF Niemeyer, KH Benam |
Pharmacology & Therapeutics | 2021 |
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
J Carrillo, N Izquierdo-Useros, C Ávila-Nieto, E Pradenas, B Clotet, J Blanco |
Biochemical and Biophysical Research Communications | 2021 |
Personalized therapy: can it tame the COVID-19 monster?
M Arish, F Naz |
Personalized Medicine | 2021 |
Monocytes and macrophages in COVID-19: Friends and foes
S Meidaninikjeh, N Sabouni, HZ Marzouni, S Bengar, A Khalili, R Jafari |
Life Sciences | 2021 |
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
J Neidleman, X Luo, AF George, M McGregor, J Yang, C Yun, V Murray, G Gill, WC Greene, J Vasquez, SA Lee, E Ghosn, KL Lynch, NR Roan |
Cell Reports | 2021 |
Reaktionsmuster der lokoregionären Lymphknoten im Abflussgebiet von COVID-19-Lungen
JD Haslbauer, MS Matter, AK Stalder, A Tzankov |
Der Pathologe | 2021 |
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
RW Cross, AN Prasad, V Borisevich, C Woolsey, KN Agans, DJ Deer, NS Dobias, JB Geisbert, KA Fenton, TW Geisbert |
Cell Reports | 2021 |
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
NA Valdez-Cruz, E García-Hernández, C Espitia, L Cobos-Marín, C Altamirano, CG Bando-Campos, LF Cofas-Vargas, EW Coronado-Aceves, RA González-Hernández, P Hernández-Peralta, D Juárez-López, PA Ortega-Portilla, S Restrepo-Pineda, P Zelada-Cordero, MA Trujillo-Roldán |
Microbial cell factories | 2021 |
Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development
SB Halstead |
BioDrugs | 2021 |
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
FM Munoz, JP Cramer, CL Dekker, MZ Dudley, BS Graham, M Gurwith, B Law, S Perlman, FP Polack, JM Spergel, EV Braeckel, BJ Ward, AM Didierlaurent, PH Lambert |
Vaccine | 2021 |
Histomorphological patterns of regional lymph nodes in COVID-19 lungs
JD Haslbauer, MS Matter, AK Stalder, A Tzankov |
Der Pathologe | 2021 |
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
BM Gunn, R Lu, MD Slein, PA Ilinykh, K Huang, C Atyeo, SL Schendel, J Kim, C Cain, V Roy, TJ Suscovich, A Takada, PJ Halfmann, Y Kawaoka, MG Pauthner, M Momoh, A Goba, L Kanneh, KG Andersen, JS Schieffelin, D Grant, RF Garry, EO Saphire, A Bukreyev, G Alter |
Immunity | 2021 |
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
L Guo, Y Wang, L Kang, Y Hu, L Wang, J Zhong, H Chen, L Ren, X Gu, G Wang, C Wang, X Dong, C Wu, L Han, Y Wang, G Fan, X Zou, H Li, J Xu, Q Jin, B Cao, J Wang |
Emerging Microbes & Infections | 2021 |
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
BM Bakadia, F He, T Souho, L Lamboni, MW Ullah, BO Boni, AA Ahmed, BM Mukole, G Yang |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19
L Núñez-Muñoz, G Marcelino-Pérez, B Calderón-Pérez, M Pérez-Saldívar, K Acosta-Virgen, H González-Conchillos, B Vargas-Hernández, A Olivares-Martínez, R Ruiz-Medrano, D Roa-Velázquez, E Morales-Ríos, J Ramos-Flores, G Torres-Franco, D Peláez-González, J Fernández-Hernández, M Espinosa-Cantellano, D Tapia-Sidas, JA Ramírez-Pool, A Padilla-Viveros, B Xoconostle-Cázares |
Human vaccines | 2021 |
Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
N Hudakova, S Hricikova, A Kulkarni, M Bhide, E Kontsekova, D Cizkova |
Pathogens | 2021 |
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
DO Ricke |
Frontiers in immunology | 2021 |
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
Y Li, Z Xu, Q Lei, D Lai, H Hou, H Jiang, Y Zheng, X Wang, J Wu, M Ma, B Zhang, H Chen, C Yu, J Xue, H Zhang, H Qi, S Guo, Y Zhang, X Lin, Z Yao, H Sheng, Z Sun, F Wang, X Fan, S Tao |
Cell Reports | 2021 |
COVID-19 in Immunosuppressed Children
E Nicastro, L Verdoni, LR Bettini, G Zuin, A Balduzzi, G Montini, A Biondi, L D'Antiga |
Frontiers in Pediatrics | 2021 |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
P Bégin, J Callum, NM Heddle, R Cook, MP Zeller, A Tinmouth, DA Fergusson, MM Cushing, MJ Glesby, M Chassé, DV Devine, N Robitalle, R Bazin, N Shehata, A Finzi, A McGeer, DC Scales, L Schwartz, AF Turgeon, R Zarychanski, N Daneman, R Carl, L Amorim, C Gabe, M Ellis, BS Sachais, KC Loftsgard, E Jamula, J Carruthers, J Duncan, K Lucier, N Li, Y Liu, C Armali, A Kron, D Modi, MC Auclair, S Cerro, M Avram, DM Arnold |
Trials | 2021 |
Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
YW Kang, S Park, KJ Lee, D Moon, YM Kim, SW Lee |
Immune Network | 2021 |
AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2
G Mazzocco, I Niemiec, A Myronov, P Skoczylas, J Kaczmarczyk, A Sanecka-Duin, K Gruba, P Król, M Drwal, M Szczepanik, K Pyrc, P Stȩpniak |
Frontiers in Genetics | 2021 |
Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
E Lee, JE Oh |
Molecules and Cells | 2021 |
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
Y Zhou, Z Liu, S Li, W Xu, Q Zhang, IT Silva, C Li, Y Wu, Q Jiang, Z Liu, Q Wang, Y Guo, J Wu, C Gu, X Cai, D Qu, CT Mayer, X Wang, S Jiang, T Ying, Z Yuan, Y Xie, Y Wen, L Lu, Q Wang |
Cell Reports | 2021 |
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
D Centonze, MA Rocca, C Gasperini, L Kappos, HP Hartung, M Magyari, C Oreja-Guevara, M Trojano, H Wiendl, M Filippi |
Journal of Neurology | 2021 |
COVID-19 Immunobiology: Lessons Learned, New Questions Arise
A Kaklamanos, K Belogiannis, P Skendros, VG Gorgoulis, PG Vlachoyiannopoulos, AG Tzioufas |
Frontiers in immunology | 2021 |
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
A Julià, I Bonafonte-Pardàs, A Gómez, M López-Lasanta, M López-Corbeto, SH Martínez-Mateu, J Lladós, I Rodríguez-Nunez, RM Myers, S Marsal |
Scientific Reports | 2021 |
Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease
JP Hussman |
Frontiers in Medicine | 2021 |
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
Y Shang, T Liu, J Li, NM Kaweme, X Wang, F Zhou |
Frontiers in immunology | 2021 |
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Q Zhang, R Xiang, S Huo, Y Zhou, S Jiang, Q Wang, F Yu |
Signal Transduction and Targeted Therapy | 2021 |
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
Z Khoshkam, Y Aftabi, P Stenvinkel, BP Lawrence, MH Rezaei, G Ichihara, S Fereidouni |
Journal of Advanced Research | 2021 |
Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19
F Pinotti, PS Wikramaratna, U Obolski, RS Paton, DS Damineli, LC Alcantara, M Giovanetti, S Gupta, J Lourenço |
BMC Medicine | 2021 |
Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
SE Faustini, SE Jossi, M PerezToledo, AM Shields, JD Allen, Y Watanabe, ML Newby, A Cook, CR Willcox, M Salim, M Goodall, JL Heaney, E MarcialJuarez, GL Morley, B Torlinska, DC Wraith, TV Veenith, S Harding, S Jolles, MJ Ponsford, T Plant, A Huissoon, MK O'Shea, BE Willcox, MT Drayson, M Crispin, AF Cunningham, AG Richter |
Immunology | 2021 |
Safety and Considerations of the COVID-19 Vaccine Massive Deployment
J Li, M Song, D Guo, Y Yi |
Virologica Sinica | 2021 |
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
B Wang, YS Goh, T Prince, EZ Ngoh, SN Salleh, PX Hor, CY Loh, SW Fong, C Hartley, SY Tan, BE Young, YS Leo, DC Lye, S Maurer-Stroh, LF Ng, JA Hiscox, L Renia, CI Wang |
npj Vaccines | 2021 |
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
M Pandey, V Ozberk, S Eskandari, AO Shalash, MA Joyce, HA Saffran, CJ Day, A Lepletier, BL Spillings, JL Mills, A Calcutt, F Fan, JT Williams, DI Stanisic, L Hattingh, J Gerrard, M Skwarczynski, J Mak, MP Jennings, I Toth, DL Tyrrell, MF Good |
IBMS BoneKEy | 2021 |
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus
P Bose, P Sunita, SP Pattanayak |
Current Microbiology | 2021 |
Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children
MR Chen, HC Kuo, YJ Lee, H Chi, SC Li, HC Lee, KD Yang |
Frontiers in immunology | 2021 |
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
NC Kyriakidis, A López-Cortés, EV González, AB Grimaldos, EO Prado |
npj Vaccines | 2021 |
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
GA Sánchez-Zuno, MG Matuz-Flores, G González-Estevez, F Nicoletti, FJ Turrubiates-Hernández, K Mangano, JF Muñoz-Valle |
International journal of immunopathology and pharmacology | 2021 |
When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
Y Taoufik, MG de Goër de Herve, S Corgnac, A Durrbach, F Mami-Chouaib |
Frontiers in immunology | 2021 |
Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model
C Li, YX Chen, FF Liu, AC Lee, Y Zhao, ZH Ye, JP Cai, H Chu, RQ Zhang, KH Chan, KH Chiu, DC Lung, S Sridhar, IF Hung, KK To, AJ Zhang, JF Chan, KY Yuen |
Clinical Infectious Diseases | 2021 |
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
S Esposito, N Principi |
Pediatric Drugs | 2021 |
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series
J Erber, JR Wiessner, C Huberle, J Schneider, H Mijočević, D von Bomhard, P Luppa, RM Schmid, S Rasch, T Lahmer |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Y Li, M Ma, Q Lei, F Wang, W Hong, D Lai, H Hou, Z Xu, B Zhang, H Chen, C Yu, J Xue, Y Zheng, X Wang, H Jiang, H Zhang, H Qi, S Guo, Y Zhang, X Lin, Z Yao, J Wu, H Sheng, Y Zhang, H Wei, Z Sun, X Fan, S Tao |
Cell Reports | 2021 |
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
AO Hassan, F Feldmann, H Zhao, DT Curiel, A Okumura, TL Tang-Huau, JB Case, K Meade-White, J Callison, RE Chen, J Lovaglio, PW Hanley, DP Scott, DH Fremont, H Feldmann, MS Diamond |
Cell reports. Medicine | 2021 |
Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19)
M Basu, S Das |
Indian Journal of Clinical Biochemistry | 2021 |
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
W Zhang, Y Meng, L Yang, M Shen, L Zhou, R Li, Y Wang, W Du, Y Xiong, Y Han, X Zhang, L Liu, X Ren |
Cancer biology & medicine | 2021 |
Non-human primate models of human respiratory infections
J Lemaitre, T Naninck, B Delache, J Creppy, P Huber, M Holzapfel, C Bouillier, V Contreras, F Martinon, N Kahlaoui, Q Pascal, S Tricot, F Ducancel, L Vecellio, RL Grand, P Maisonnasse |
Molecular Immunology | 2021 |
Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
T Zhu, Y Xiao, X Meng, L Tang, B Li, Z Zhao, Q Tan, H Shan, L Liu, |
Journal of nanobiotechnology | 2021 |
Targets and strategies for vaccine development against SARS-CoV-2
JA Malik, AH Mulla, T Farooqi, FH Pottoo, S Anwar, KR Rengasamy |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
AR Daamen, P Bachali, KA Owen, KM Kingsmore, EL Hubbard, AC Labonte, R Robl, S Shrotri, AC Grammer, PE Lipsky |
Scientific Reports | 2021 |
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
CE Chan, SG Seah, DH Chye, S Massey, M Torres, AP Lim, SK Wong, JJ Neo, PS Wong, JH Lim, GS Loh, D Wang, JD Boyd-Kirkup, S Guan, D Thakkar, GH Teo, K Purushotorman, PE Hutchinson, BE Young, JG Low, PA MacAry, H Hentze, VS Prativadibhayankara, K Ethirajulu, JE Comer, CT Tseng, AD Barrett, PJ Ingram, T Brasel, BJ Hanson, K Harrod |
PloS one | 2021 |
A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS
Reyes L, A. Sanchez-Garcia M, Morrison T, Howden AJ, Watts ER, Arienti S, Sadiku P, Coelho P, Mirchandani AS, Zhang A, Hope D, Clark SK, Singleton J, Johnston S, Grecian R, Poon A, McNamara S, Harper I, Fourman MH, Brenes AJ, Pathak S, Lloyd A, Blanco GR, von Kriegsheim A, Ghesquiere B, Vermaelen W, Cologna CT, Dhaliwal K, Hirani N, Dockrell DH, Whyte MK, Griffith D, Cantrell DA, Walmsley SR |
Wellcome Open Research | 2021 |
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines.
Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B |
Frontiers in immunology | 2021 |
Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels
Chen H, Qin R, Huang Z, He L, Luo W, Zheng P, Huang H, Wang H, Sun B |
Frontiers in Molecular Biosciences | 2021 |
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
Zhou D, Chan JF, Zhou B, Zhou R, Li S, Shan S, Liu L, Zhang AJ, Chen SJ, Chan CC, Xu H, Poon VK, Yuan S, Li C, Chik KK, Chan CC, Cao J, Chan CY, Kwan KY, Du Z, Lau TT, Zhang Q, Zhou J, To KK, Zhang L, Ho DD, Yuen KY, Chen Z |
Cell Host & Microbe | 2021 |
COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.
Xie B, Zhang J, Li Y, Yuan S, Shang Y |
Frontiers in immunology | 2021 |
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R, Kalmarzi RN, Roghani SA |
Immunologic research | 2021 |
Overview of Nonhuman Primate Models of SARS-CoV-2
Trichel AM |
Comparative medicine | 2021 |
Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India.
Majumdar S, Verma R, Saha A, Bhattacharyya P, Maji P, Surjit M, Kundu M, Basu J, Saha S |
Frontiers in Genetics | 2021 |
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.
Widjaja G, Turki Jalil A, Sulaiman Rahman H, Abdelbasset WK, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M |
Human Immunology | 2021 |
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Aksakal A, Kerget B, Kerget F, Aşkın S |
Journal of Medical Virology | 2021 |
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N |
Journal of Infection and Chemotherapy | 2021 |
Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2
Song D, Wang W, Dong C, Ning Z, Liu X, Liu C, Du G, Sha C, Wang K, Lu J, Sun B, Zhao Y, Wang Q, Xu H, Li Y, Shen Z, Jiao J, Wang R, Tian J, Liu W, Wang L, Deng YQ, Dou C |
2021 | |
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Tian JH, Patel N, Haupt R, Zhou H, Weston S, Hammond H, Logue J, Portnoff AD, Norton J, Guebre-Xabier M, Zhou B, Jacobson K, Maciejewski S, Khatoon R, Wisniewska M, Moffitt W, Kluepfel-Stahl S, Ekechukwu B, Papin J, Boddapati S, Jason Wong C, Piedra PA, Frieman MB, Massare MJ, Fries L, Bengtsson KL, Stertman L, Ellingsworth L, Glenn G, Smith G |
Nature Communications | 2021 |
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
Zhang Y, Zhao W, Mao Y, Chen Y, Wang S, Zhong Y, Su T, Gong M, Du D, Lu X, Cheng J, Yang H |
Molecular & cellular proteomics : MCP | 2021 |
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort
Caccuri F, Bugatti A, Meini A, Bonfanti C, Motta M, Savarè L, Arrighini A, Bondioni MP, Lougaris V, Caruso A, Plebani A |
Clinical Immunology | 2021 |
COVID-19 vaccines: Frequently asked questions and updated answers
Lefebvre M, Vignier N, Pitard B, Botelho-Nevers E, Wyplosz B, Cohen R, Epaulard O |
2021 | |
Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8+ T Cell Recognition In Vivo
Takagi A, Matsui M |
Journal of virology | 2021 |
A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response
Lainšček D, Fink T, Forstnerič V, Hafner-Bratkovič I, Orehek S, Strmšek Ž, Manček-Keber M, Pečan P, Esih H, Malenšek Š, Aupič J, Dekleva P, Plaper T, Vidmar S, Kadunc L, Benčina M, Omersa N, Anderluh G, Pojer F, Lau K, Hacker D, Correia BE, Peterhoff D, Wagner R, Bergant V, Herrmann A, Pichlmair A, Jerala R |
Human vaccines | 2021 |
SARS-CoV-2: Unique Challenges of the Virus and Vaccines
Mahmoodpoor A, Sanaie S, Samadi P, Yousefi M, Nader ND |
Immunological Investigations | 2021 |
Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care
Saviano A, Wrensch F, Ghany MG, Baumert TF |
Hepatology | 2021 |
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Bertoglio F, Fühner V, Ruschig M, Heine PA, Abassi L, Klünemann T, Rand U, Meier D, Langreder N, Steinke S, Ballmann R, Schneider KT, Roth KD, Kuhn P, Riese P, Schäckermann D, Korn J, Koch A, Chaudhry MZ, Eschke K, Kim Y, Zock-Emmenthal S, Becker M, Scholz M, Moreira GM, Wenzel EV, Russo G, Garritsen HS, Casu S, Gerstner A, Roth G, Adler J, Trimpert J, Hermann A, Schirrmann T, Dübel S, Frenzel A, Van den Heuvel J, Čičin-Šain L, Schubert M, Hust M |
Cell Reports | 2021 |
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
Jiang W, Wang J, Jiao S, Gu C, Xu W, Chen B, Wang R, Chen H, Xie Y, Wang A, Li G, Zeng D, Zhang J, Zhang M, Wang S, Wang M, Gui X |
mAbs | 2021 |
Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
Bonetti TC, Latini FR, Invitti AL, Fonseca MC, Scorza FA, Saldanha MG, Bellucco FT, Bacarov NB, Soane MM, Girão MJ |
Clinics | 2021 |
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Heinz FX, Stiasny K |
npj Vaccines | 2021 |
Antibody dependent enhancement: Unavoidable problems in vaccine development
Xu L, Ma Z, Li Y, Pang Z, Xiao S |
Advances in immunology | 2021 |
Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study
Hou H, Yang H, Liu P, Huang C, Wang M, Li Y, Zhu M, Wang J, Xu Y, Wang Y, Ma Q, Li D, Liao P, Wang W |
Frontiers in immunology | 2021 |
Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab′)2 fragment derived from equine polyclonal antibodies
Salinas F, Marelli BE, Sanguineti S, Goldbaum F, Muñoz L, Etchevers L, Silvestrini P, Notaro US, Salvetti NR, Zylberman V, Ortega HH |
Toxicology and Applied Pharmacology | 2021 |
Development of an Inactivated Vaccine against SARS CoV-2
Pavel ST, Yetiskin H, Uygut MA, Aslan AF, Aydın G, İnan Ö, Kaplan B, Ozdarendeli A |
Human vaccines | 2021 |
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
Khan WH, Hashmi Z, Goel A, Ahmad R, Gupta K, Khan N, Alam I, Ahmed F, Ansari MA |
Frontiers in Cellular and Infection Microbiology | 2021 |
Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study.
Maraqa B, Basha W, Khayyat R, Abdul-Hadi AR, Jabareen J, Al-Shakhra K, Al-Kaila M, Nazzal Z |
PloS one | 2021 |
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L |
Frontiers in microbiology | 2021 |
Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein.
Li H, Zhang Y, Li D, Deng YQ, Xu H, Zhao C, Liu J, Wen D, Zhao J, Li Y, Wu Y, Liu S, Liu J, Hao J, Yuan F, Duo S, Qin CF, Zheng A |
Signal Transduction and Targeted Therapy | 2021 |
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19.
Manickam M, Meenakshisundaram S, Pillaiyar T |
Archiv der Pharmazie | 2021 |
Covid-19 pandemic: What is the truth?
Blaylock RL |
Surgical neurology international | 2021 |
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA |
ACS Central Science | 2021 |
COVID-19 Vaccine: Critical Questions with Complicated Answers
Haidere MF, Ratan ZA, Nowroz S, Zaman SB, Jung YJ, Hosseinzadeh H, Cho JY |
Biomolecules & therapeutics | 2021 |
The 2020 race towards SARS-CoV-2 specific vaccines
Karpiński TM, Ożarowski M, Seremak-Mrozikiewicz A, Wolski H, Wlodkowic D |
Theranostics | 2021 |
Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement—A Scoping Review
Malviya A, Mishra A |
2021 | |
Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19
Zhang Z, Guo L, Lu X, Zhang C, Huang L, Wang X, Duan F, Liang H, Chen P, Zeng L, Shao J, Li H, Li L, Liu L, Li C, Zhang J, Ma CY, Kwan KY, Liu W, Xu Y, Gu X, Jiang H, Du H, Zhang T, Wu Y, Yu G, Chen J, Luo R, Liao C, Tse HF, Chen Z, Chen HJ, Xia H, Lian Q |
Theranostics | 2021 |
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
Finkelstein MT, Mermelstein AG, Parker Miller E, Seth PC, Stancofski ES, Fera D |
Viruses | 2021 |
Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19
Rencilin CF, Rosy JC, Mohan M, Coico R, Sundar K |
Infection, Genetics and Evolution | 2021 |
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
Becker M, Strengert M, Junker D, Kaiser PD, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause G, Schneiderhan-Marra N |
Nature Communications | 2021 |
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19
Folgueira MD, Luczkowiak J, Lasala F, Pérez-Rivilla A, Delgado R |
Clinical Microbiology and Infection | 2021 |
Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes
Li M, Zeng J, Li R, Wen Z, Cai Y, Wallin J, Shu Y, Du X, Sun C |
Viruses | 2021 |
The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
Hassanzadeh P |
Life Sciences | 2021 |
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
Blasi F, Gramegna A, Sotgiu G, Saderi L, Voza A, Aliberti S, Amati F |
Respiratory Medicine | 2021 |
Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Li M, Zhao R, Chen J, Tian W, Xia C, Liu X, Li Y, Li S, Sun H, Shen T, Ren W, Sun L |
Scientific Reports | 2021 |
SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
Yoshida S, Ono C, Hayashi H, Fukumoto S, Shiraishi S, Tomono K, Arase H, Matsuura Y, Nakagami H |
Scientific Reports | 2021 |
SARS‐CoV‐2‐related multisystem inflammatory syndrome in an immunocompromised child with leukemia
Pandrowala A, Panchal H, Mudaliar S, Bodhanwala M, Prabhu S, Jain S, Mishra J, Hiwarkar P |
Pediatric Blood & Cancer | 2021 |
Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
Ferrantelli F, Chiozzini C, Manfredi F, Giovannelli A, Leone P, Federico M |
Human vaccines | 2021 |
Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
Tanmay S, Labrou D, Farsalinos K, Poulas K |
Food and Chemical Toxicology | 2021 |
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data
Khare S, Azevedo M, Parajuli P, Gokulan K |
2021 | |
RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
Lopardo G, Belloso WH, Nannini E, Colonna M, Sanguineti S, Zylberman V, Muñoz L, Dobarro M, Lebersztein G, Farina J, Vidiella G, Bertetti A, Crudo F, Alzogaray MF, Barcelona L, Teijeiro R, Lambert S, Scublinsky D, Iacono M, Stanek V, Solari R, Cruz P, Casas MM, Abusamra L, Luciardi HL, Cremona A, Caruso D, de Miguel B, Lloret SP, Millán S, Kilstein Y, Pereiro A, Sued O, Cahn P, Spatz L, Goldbaum F |
2021 | |
Application of a recombinant replicase to localize the Trionyx sinensis hemorrhagic syndrome virus and evaluate its effects on antiviral genes of T. sinensis
LYU S, YUAN X, LIU L, ZHANG H, YU Z, HANG X, SHI W, WU Y |
Journal of Zhejiang University. Science. B | 2021 |
Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience
Villalta D, Martelli P, Moratto A, Salgarolo V, Ligato E, Conte M, Giacomello R, Pellis T, De Rosa R, Venturini S, Crapis M |
Practical Laboratory Medicine | 2021 |
An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
Kathiravan MK, Radhakrishnan S, Namasivayam V, Palaniappan S |
Frontiers in Molecular Biosciences | 2021 |
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH, Lin YL |
Scientific Reports | 2021 |
Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines
Hofman K, Shenoy GN, Chak V, Balu-Iyer SV |
Immunological Investigations | 2021 |
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura Á, Gómez A, Solano G, Corrales-Aguilar E, Risner K, Narayanan A, Bailey C, Villalta M, Hernández A, Sánchez A, Cordero D, Solano D, Durán G, Segura E, Cerdas M, Umaña D, Moscoso E, Estrada R, Gutiérrez J, Méndez M, Castillo AC, Sánchez L, Sánchez R, Gutiérrez JM, Díaz C, Alape A |
Scientific Reports | 2021 |
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
McDonald I, Murray SM, Reynolds CJ, Altmann DM, Boyton RJ |
npj Vaccines | 2021 |
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
Gary EN, Warner BM, Parzych EM, Griffin BD, Zhu X, Tailor N, Tursi NJ, Chan M, Purwar M, Vendramelli R, Choi J, Frost KL, Reeder S, Liaw K, Tello E, Ali AR, Yun K, Pei Y, Thomas SP, Rghei AD, Guilleman MM, Muthumani K, Smith T, Wootton SK, Patel A, Weiner DB, Kobasa D |
iScience | 2021 |
A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates
Yang L, Tian D, Han JB, Fan W, Zhang Y, Li Y, Sun W, Wei Y, Tian X, Yu DD, Feng XL, Cheng G, Bi Y, Zheng YT, Liu W |
2021 | |
What gastroenterologists should know about SARS–CoV 2 vaccine: World Endoscopy Organization perspective
Spadaccini M, Canziani L, Aghemo A, Lleo A, Maselli R, Anderloni A, Carrara S, Fugazza A, Pellegatta G, Galtieri PA, Hassan C, Greenwald D, Pochapin M, Wallace M, Sharma P, Roesch T, Bhandari P, Emura F, Raju GS, Repici A |
United European gastroenterology journal | 2021 |
Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID‐19 Cytokine Storm
Meng Q, Tian R, Long H, Wu X, Lai J, Zharkova O, Wang J, Chen X, Rao L |
Advanced materials (Deerfield Beach, Fla.) | 2021 |
Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe
Wagner R, Meißner J, Grabski E, Sun Y, Vieths S, Hildt E |
Allergy | 2021 |
Immune cell profiling and antibody responses in patients with COVID-19
Rezaei M, Mahmoudi S, Mortaz E, Marjani M |
BMC Infectious Diseases | 2021 |
SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways
Giardino G, Romano R, Coppola E, Cillo F, Borzachiello C, De Luca M, Palamaro L, Toriello E, Prencipe R, Cirillo E, Pignata C |
The journal of allergy and clinical immunology. In practice | 2021 |
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study
Wu X, Li N, Wang G, Liu W, Yu J, Cao G, Wang J, Chen Y, Ma J, Wu J, Yang H, Mao X, He J, Yu Y, Qiu C, Li N, Yao S, Feng H, Yan J, Zhang W, Zhang J |
Antimicrobial agents and chemotherapy | 2021 |
Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks
Wagner R, Hildt E, Grabski E, Sun Y, Meyer H, Lommel A, Keller-Stanislawski B, Müller-Berghaus J, Cichutek K |
Human vaccines | 2021 |
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Martínez-Flores D, Zepeda-Cervantes J, Cruz-Reséndiz A, Aguirre-Sampieri S, Sampieri A, Vaca L |
Frontiers in immunology | 2021 |
Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19
Ren P, Zhu C, He Y, Jiang H, Chen J |
Annals of translational medicine | 2021 |
Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
Cheng ZJ, Xue M, Zheng P, Lyu J, Zhan Z, Hu H, Zhang Y, Zhang XD, Sun B |
Human vaccines | 2021 |
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
Sun CP, Jan JT, Wang IH, Ma HH, Ko HY, Wu PY, Kuo TJ, Liao HN, Lan YH, Sie ZL, Chen YH, Ko YA, Liao CC, Chen LY, Lee IJ, Tsung SI, Lai YJ, Chiang MT, Liang JJ, Liu WC, Wang JR, Yuan JP, Lin YS, Tsai YC, Hsieh SL, Li CW, Wu HC, Ko TM, Lin YL, Tao MH |
PLoS pathogens | 2021 |
Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19
Ahmadi AR, Ayazi-Nasrabadi R |
Iranian Journal of Microbiology | 2021 |
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
Sun W, He L, Zhang H, Tian X, Bai Z, Sun L, Yang L, Jia X, Bi Y, Luo T, Cheng G, Fan W, Liu W, Li J |
Signal Transduction and Targeted Therapy | 2021 |
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.
Clark NM, Janaka SK, Hartman W, Stramer S, Goodhue E, Weiss J, Evans DT, Connor JP |
2021 | |
Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
Ehianeta T, Mzee SA, Adebisi MK, Ehianeta O |
2021 | |
Impact of rituximab on COVID-19 outcomes
Levavi H, Lancman G, Gabrilove J |
Annals of Hematology | 2021 |
Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination
Hasan A, Al-Mulla MR, Abubaker J, Al-Mulla F |
Human Vaccines & Immunotherapeutics | 2021 |
Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity.
Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA |
bioRxiv : the preprint server for biology | 2021 |
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee S, Ghosn E, Lynch K, Roan NR |
2021 | |
COVID-19 associated multisystem inflammatory syndrome in children mimicking acute appendicitis - how to differentiate and conduct pediatric patients during the pandemic? - Proposal of a management flowchart
FALQUETO LE, VISSOCI CM, FERREIRA IC, ANTUNES AG, AMADO FA, AVILLA SA, SCHULZ C, MOTTA FA, SILVA ED |
Revista do Colégio Brasileiro de Cirurgiões | 2021 |
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, Rickey E. Carter, Allan M. Klompas, Chad C. Wiggins, John R.A. Shepherd, Robert F. Rea, Emily R. Whelan, Andrew J. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, David O. Hodge, Katie L. Kunze, Matthew R. Buras, Matthew N.P. Vogt, Vitaly Herasevich, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Nigel S. Paneth, Nicole C. Verdun, Peter Marks, Arturo Casadevall |
Journal of Clinical Investigation | 2020 |
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
J Zhang, Y Hao, W Ou, F Ming, G Liang, Y Qian, Q Cai, S Dong, S Hu, W Wang, S Wei |
Journal of Translational Medicine | 2020 |
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Sian E Faustini, Sian E Jossi, Marisol Perez-Toledo, Adrian Shields, Joel D Allen, Yasunori Watanabe, Maddy L Newby, Alex Cook, Carrie R Willcox, Mahboob Salim, Margaret Goodall, Jennifer L Heaney, Edith Marcial-Juarez, Gabriella L Morley, Barbara Torlinska, David C Wraith, Tonny Veenith, Stephen Harding, Stephen Jolles, Ponsford J Mark, Tim Plant, Aarnoud Huissoon, Matthew K O'Shea, Benjamin E Willcox, Mark T Drayson, Max Crispin, Adam F Cunningham, Alex G Richter |
||
Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰
L Liu, Q Lin, J Peng, J Fang, Z Tan, H Tang, K Kwan, K Nishiura, J Liang, H Kwok, Z Du, J Sun, K Liu, KY Yuen, H Wang, Z Chen |
EBioMedicine | 2020 |
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, SS Alamri, KA Alluhaybi, HI Hobani, RH AlHarbi, RM Alsulaiman, MZ ElAssouli, S Hala, NK Alharbi, RY Alhabbab, AA AlSaieedi, WH Abdulaal, A Bukhari, AA AL-Somali, FS Alofi, AA Khogeer, A Pain, AA Alkayyal, NA Almontashiri, BM Ahmad, X Li |
Viruses | 2020 |
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
D Kanduc |
Antibodies | 2020 |
Why does COVID-19 disproportionately affect older people?
AL Mueller, MS McNamara, DA Sinclair |
Aging | 2020 |
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
AJ Pietrobon, FM Teixeira, MN Sato |
Frontiers in immunology | 2020 |
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Y Rodríguez, L Novelli, M Rojas, MD Santis, Y Acosta-Ampudia, DM Monsalve, C Ramírez-Santana, A Costanzo, WM Ridgway, AA Ansari, ME Gershwin, C Selmi, JM Anaya |
Journal of Autoimmunity | 2020 |
COVID‐19, varying genetic resistance to viral disease and immune tolerance checkpoints
CC Goodnow |
Immunology and Cell Biology | 2020 |
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
TO Kleen, AA Galdon, AS MacDonald, AG Dalgleish |
Frontiers in immunology | 2020 |
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack
EM Frohman, NR Villemarette-Pittman, RA Cruz, R Longmuir, V Rowe, ES Rowe, TC Varkey, L Steinman, SS Zamvil, TC Frohman |
Journal of the Neurological Sciences | 2020 |
COVID-19 antibodies on trial
L DeFrancesco |
Nature Biotechnology | 2020 |
Mechanistic inferences from clinical reports of SARS-CoV-2
MM Jenkins, TR McCaw, PA Goepfert |
Infectious Diseases | 2020 |
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
X Liu, W Cao, T Li |
Frontiers in immunology | 2020 |
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
NM de Queiroz, FV Marinho, MA Chagas, LC Leite, EJ Homan, MT de Magalhães, SC Oliveira |
Microbes and infection / Institut Pasteur | 2020 |
The role of IgG Fc receptors in antibody-dependent enhancement
S Bournazos, A Gupta, JV Ravetch |
Nature Reviews Immunology | 2020 |
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19
M Pawlitzki, UK Zettl, T Ruck, L Rolfes, HP Hartung, SG Meuth |
EBioMedicine | 2020 |
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
N Taefehshokr, S Taefehshokr, B Heit |
Pathogens | 2020 |
Identification of a metabolic gene panel to predict the prognosis of myelodysplastic syndrome
F Hu, S Chen, Y Dai, Y Wang, Z Qin, H Li, L Shu, J Li, H Huang, Y Liang |
Journal of Cellular and Molecular Medicine | 2020 |
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
M Merad, JC Martin |
Nature Reviews Immunology | 2020 |
Immunometabolic Status of COVID-19 Cancer Patients
A Sica, MP Colombo, A Trama, L Horn, MC Garassino, V Torri |
Physiological reviews | 2020 |
The trinity of COVID-19: immunity, inflammation and intervention
MZ Tay, CM Poh, L Rénia, PA MacAry, LF Ng |
Nature Reviews Immunology | 2020 |
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, SA Rawlings, A Sutherland, L Premkumar, RS Jadi, D Marrama, AM de Silva, A Frazier, AF Carlin, JA Greenbaum, B Peters, F Krammer, DM Smith, S Crotty, A Sette |
Cell | 2020 |
Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
M Hajivalili, M Hosseini, M Haji-Fatahaliha |
Life Sciences | 2020 |
Lessons for COVID-19 Immunity from Other Coronavirus Infections
A Sariol, S Perlman |
Immunity | 2020 |
Immune responses during COVID-19 infection
C Melenotte, A Silvin, AG Goubet, I Lahmar, A Dubuisson, A Zumla, D Raoult, M Merad, B Gachot, C Hénon, E Solary, M Fontenay, F André, M Maeurer, G Ippolito, M Piacentini, FS Wang, F Ginhoux, A Marabelle, G Kroemer, L Derosa, L Zitvogel |
OncoImmunology | 2020 |
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Y Zhang, B Li, B Ning |
Frontiers in immunology | 2020 |
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
M Sokolowska, ZM Lukasik, I Agache, CA Akdis, D Akdis, M Akdis, W Barcik, HA Brough, T Eiwegger, A Eljaszewicz, S Eyerich, W Feleszko, C GomezCasado, K HoffmannSommergruber, J Janda, R JiménezSaiz, M Jutel, EF Knol, IK Krohn, A Kothari, J Makowska, M Moniuszko, H Morita, L O'Mahony, K Nadeau, C Ozdemir, I PaliSchöll, O Palomares, F Papaleo, M Prunicki, CB SchmidtWeber, A Sediva, J Schwarze, MH Shamji, GA TramperStranders, W Veen, E Untersmayr |
Allergy | 2020 |
Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown
T Zrzavy, I Wimmer, PS Rommer, T Berger |
European journal of neurology : the official journal of the European Federation of Neurological Societies | 2020 |
Facing SARS-CoV-2 outbreak in immunotherapy era
F Citarella, M Russano, F Pantano, E Dell'Aquila, B Vincenzi, G Tonini, D Santini |
Future Oncology | 2020 |
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
G Chauhan, MJ Madou, S Kalra, V Chopra, D Ghosh, SO Martinez-Chapa |
ACS Nano | 2020 |
The potential danger of suboptimal antibody responses in COVID-19
A Iwasaki, Y Yang |
Nature Reviews Immunology | 2020 |
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
SN Amrun, CY Lee, B Lee, SW Fong, BE Young, RS Chee, NK Yeo, A Torres-Ruesta, G Carissimo, CM Poh, ZW Chang, MZ Tay, YH Chan, MI Chen, JG Low, PA Tambyah, S Kalimuddin, S Pada, SY Tan, LJ Sun, YS Leo, DC Lye, L Renia, LF Ng |
EBioMedicine | 2020 |
The lethal sex gap: COVID-19
EJ Márquez, J Trowbridge, GA Kuchel, J Banchereau, D Ucar |
Immunity & Ageing | 2020 |
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
T Zhou, TT Su, T Mudianto, J Wang |
Journal of Experimental Medicine | 2020 |
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
R Zhou, KK To, YC Wong, L Liu, B Zhou, X Li, H Huang, Y Mo, TY Luk, TT Lau, P Yeung, WM Chan, AK Wu, KC Lung, OT Tsang, WS Leung, IF Hung, KY Yuen, Z Chen |
Immunity | 2020 |
Implications of COVID-19 in pediatric rheumatology
ED Batu, S Özen |
Rheumatology International | 2020 |
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
R de Alwis, S Chen, ES Gan, EE Ooi |
EBioMedicine | 2020 |
Immunology of COVID-19: Current State of the Science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, L Malle, A Moreira, MD Park, L Pia, E Risson, M Saffern, B Salomé, ME Selvan, MP Spindler, J Tan, V van der Heide, JK Gregory, K Alexandropoulos, N Bhardwaj, BD Brown, B Greenbaum, ZH Gümüş, D Homann, A Horowitz, AO Kamphorst, MA de Lafaille, S Mehandru, M Merad, RM Samstein, M Agrawal, M Aleynick, M Belabed, M Brown, M Casanova-Acebes, J Catalan, M Centa, A Charap, A Chan, ST Chen, J Chung, CC Bozkus, E Cody, F Cossarini, E Dalla, N Fernandez, J Grout, DF Ruan, P Hamon, E Humblin, D Jha, J Kodysh, A Leader, M Lin, K Lindblad, D Lozano-Ojalvo, G Lubitz, A Magen, Z Mahmood, G Martinez-Delgado, J Mateus-Tique, E Meritt, C Moon, J Noel, T ODonnell, M Ota, T Plitt, V Pothula, J Redes, IR Torres, M Roberto, AR Sanchez-Paulete, J Shang, AS Schanoski, M Suprun, M Tran, N Vaninov, CM Wilk, J Aguirre-Ghiso, D Bogunovic, J Cho, J Faith, E Grasset, P Heeger, E Kenigsberg, F Krammer, U Laserson |
Immunity | 2020 |
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Y Fu, Y Cheng, Y Wu |
Virologica Sinica | 2020 |
The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
PJ Hotez, ME Bottazzi, DB Corry |
Microbes and infection / Institut Pasteur | 2020 |
Animal models for emerging coronavirus: progress and new insights
L Yuan, Q Tang, T Cheng, N Xia |
Emerging Microbes & Infections | 2020 |
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
PM Folegatti, M Bittaye, A Flaxman, FR Lopez, D Bellamy, A Kupke, C Mair, R Makinson, J Sheridan, C Rohde, S Halwe, Y Jeong, YS Park, JO Kim, M Song, A Boyd, N Tran, D Silman, I Poulton, M Datoo, J Marshall, Y Themistocleous, A Lawrie, R Roberts, E Berrie, S Becker, T Lambe, A Hill, K Ewer, S Gilbert |
The Lancet Infectious Diseases | 2020 |
Promise and challenges in the development of COVID-19 vaccines
W Chen |
Human Vaccines & Immunotherapeutics | 2020 |
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
S Lega, S Naviglio, S Volpi, A Tommasini |
Human vaccines | 2020 |
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
JP Moore, PJ Klasse, G Silvestri |
Journal of virology | 2020 |
An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design
CV Herst, S Burkholz, J Sidney, A Sette, PE Harris, S Massey, T Brasel, E Cunha-Neto, DS Rosa, WC Chao, R Carback, T Hodge, L Wang, S Ciotlos, P Lloyd, R Rubsamen |
Vaccine | 2020 |
Immunotherapeutic approaches to curtail COVID-19
H Owji, M Negahdaripour, N Hajighahramani |
International Immunopharmacology | 2020 |
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis
MA Schramm, N Venhoff, D Wagner, J Thiel, D Huzly, N Craig-Mueller, M Panning, H Hengel, WV Kern, RE Voll |
Frontiers in immunology | 2020 |
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
MP Cheng, CP Yansouni, NE Basta, M Desjardins, S Kanjilal, K Paquette, C Caya, M Semret, C Quach, M Libman, L Mazzola, JA Sacks, S Dittrich, J Papenburg |
Annals of internal medicine | 2020 |
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
P Bost, A Giladi, Y Liu, Y Bendjelal, G Xu, E David, R Blecher-Gonen, M Cohen, C Medaglia, H Li, A Deczkowska, S Zhang, B Schwikowski, Z Zhang, I Amit |
Cell | 2020 |
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
B Zhang, X Zhou, C Zhu, Y Song, F Feng, Y Qiu, J Feng, Q Jia, Q Song, B Zhu, J Wang |
Frontiers in Molecular Biosciences | 2020 |
Anti-SARS-CoV-2 hyperimmune plasma workflow
P Annamaria, Q Eugenia, S Paolo |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
Potential role of interferons in treating COVID-19 patients
MH Abdolvahab, S Moradi-kalbolandi, M Zarei, D Bose, K Majidzadeh-A, L Farahmand |
International Immunopharmacology | 2020 |
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis
L Wang, Y Shen, M Li, H Chuang, Y Ye, H Zhao, H Wang |
Journal of Neurology | 2020 |
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
L Feng, Q Wang, C Shan, C Yang, Y Feng, J Wu, X Liu, Y Zhou, R Jiang, P Hu, X Liu, F Zhang, P Li, X Niu, Y Liu, X Zheng, J Luo, J Sun, Y Gu, B Liu, Y Xu, C Li, W Pan, J Zhao, C Ke, X Chen, T Xu, N Zhong, S Guan, Z Yuan, L Chen |
Nature Communications | 2020 |
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
H Wurm, K Attfield, AK Iversen, R Gold, L Fugger, A Haghikia |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2020 |
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
X Ma, F Zou, F Yu, R Li, Y Yuan, Y Zhang, X Zhang, J Deng, T Chen, Z Song, Y Qiao, Y Zhan, J Liu, J Zhang, X Zhang, Z Peng, Y Li, Y Lin, L Liang, G Wang, Y Chen, Q Chen, T Pan, X He, H Zhang |
Immunity | 2020 |
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois |
Frontiers in immunology | 2020 |
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
L Lu, H Zhang, M Zhan, J Jiang, H Yin, DJ Dauphars, SY Li, Y Li, YW He |
Science China Life Sciences | 2020 |
COVID-19-neutralizing antibodies predict disease severity and survival
WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, BM Hauser, TM Caradonna, KL Clayton, AD Nitido, MR Murali, G Alter, RC Charles, A Dighe, JA Branda, JK Lennerz, D Lingwood, AG Schmidt, AJ Iafrate, AB Balazs |
Cell | 2020 |
SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions
P Asrani, I Hassan |
Molecular and Cellular Biochemistry | 2020 |
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
T Ahmad, R Chaudhuri, MC Joshi, A Almatroudi, AH Rahmani, SM Ali |
Frontiers in microbiology | 2020 |
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
R Kumar, MH Lee, C Mickael, B Kassa, Q Pasha, R Tuder, B Graham |
ERJ Open Research | 2020 |
Monocyte activation in systemic Covid-19 infection: Assay and rationale
FO Martinez, TW Combes, F Orsenigo, S Gordon |
EBioMedicine | 2020 |
A Thermostable mRNA Vaccine against COVID-19
NN Zhang, XF Li, YQ Deng, H Zhao, YJ Huang, G Yang, WJ Huang, P Gao, C Zhou, RR Zhang, Y Guo, SH Sun, H Fan, SL Zu, Q Chen, Q He, TS Cao, XY Huang, HY Qiu, JH Nie, Y Jiang, HY Yan, Q Ye, X Zhong, XL Xue, ZY Zha, D Zhou, X Yang, YC Wang, B Ying, CF Qin |
Cell | 2020 |
COVID-19: Coronavirus Vaccine Development Updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan, X Wu, Y Yan, W Zhao, J Wu, J Chodosh, Q Zhang |
Frontiers in immunology | 2020 |
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, A Barratt-Due, M Sokolova, C Schjalm, V Chaban, A Kolderup, T Tran, TT Gjølberg, LG Skeie, L Hesstvedt, V Ormåsen, B Fevang, C Austad, KE Müller, C Fladeby, M Holberg-Petersen, B Halvorsen, F Müller, P Aukrust, S Dudman, T Ueland, JT Andersen, F Lund-Johansen, L Heggelund, AM Dyrhol-Riise, TE Mollnes |
Proceedings of the National Academy of Sciences | 2020 |
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
R Ramezankhani, R Solhi, A Memarnejadian, F Nami, SM Hashemian, T Tricot, M Vosough, C Verfaillie |
International Journal of Antimicrobial Agents | 2020 |
Dissecting antibody-mediated protection against SARS-CoV-2
T Zohar, G Alter |
Nature Reviews Immunology | 2020 |
Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
F Cappello, AM Gammazza, F Dieli, EC de Macario, AJ Macario |
Journal of Clinical Medicine | 2020 |
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic
A Ngo, D Masel, C Cahill, N Blumberg, MA Refaai |
Clinics in Laboratory Medicine | 2020 |
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
JP Hussman |
Frontiers in pharmacology | 2020 |
Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
J Ouyang, S Isnard, J Lin, B Fombuena, X Peng, JP Routy, Y Chen |
Frontiers in immunology | 2020 |
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
M Thijssen, T Devos, HS Ejtahed, S Amini-Bavil-Olyaee, AA Pourfathollah, MR Pourkarim |
Microorganisms | 2020 |
Antibody-dependent enhancement and COVID-19: Moving toward acquittal
EJ Yager |
Clinical Immunology | 2020 |
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy |
Immunological Reviews | 2020 |
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara, CM Hedrich |
Clinical Immunology | 2020 |
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
CD Andrews, Y Huang, DD Ho, RA Liberatore |
Emerging Microbes & Infections | 2020 |
Immunological considerations for COVID-19 vaccine strategies
M Jeyanathan, S Afkhami, F Smaill, MS Miller, BD Lichty, Z Xing |
Nature Reviews Immunology | 2020 |
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
GD Sempowski, KO Saunders, P Acharya, KJ Wiehe, BF Haynes |
Cell | 2020 |
Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon, M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon |
Critical Care | 2020 |
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
A Beretta, M Cranage, D Zipeto |
Frontiers in immunology | 2020 |
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
RM Zellweger, TA Wartel, F Marks, M Song, JH Kim |
Expert Review of Vaccines | 2020 |
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
G Guo, L Ye, K Pan, Y Chen, D Xing, K Yan, Z Chen, N Ding, W Li, H Huang, L Zhang, X Li, X Xue |
Frontiers in Cell and Developmental Biology | 2020 |
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
BM Jarai, Z Stillman, K Bomb, AM Kloxin, CA Fromen |
ACS Biomaterials Science & Engineering | 2020 |
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
RP Saha, AR Sharma, MK Singh, S Samanta, S Bhakta, S Mandal, M Bhattacharya, SS Lee, C Chakraborty |
Frontiers in pharmacology | 2020 |
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore |
eLife | 2020 |
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, A Sabzevari, G Azizi |
Scandinavian Journal of Immunology | 2020 |
Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira, M Pinheiro |
2020 | |
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
S Iacob, DG Iacob |
Frontiers in pharmacology | 2020 |
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
P Domingo, I Mur, V Pomar, H Corominas, J Casademont, N de Benito |
EBioMedicine | 2020 |
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
E Sinderewicz, W Czelejewska, K Jezierska-Wozniak, J Staszkiewicz-Chodor, W Maksymowicz |
Pathogens | 2020 |
COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink |
Journal der Deutschen Dermatologischen Gesellschaft | 2020 |
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
A Rauf, T Abu-Izneid, A Olatunde, AA Khalil, FA Alhumaydhi, T Tufail, MA Shariati, M Rebezov, ZM Almarhoon, YN Mabkhot, A Alsayari, KR Rengasamy |
International journal of environmental research and public health | 2020 |
Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
A Arashkia, S Jalilvand, N Mohajel, A Afchangi, K Azadmanesh, M SalehiVaziri, M Fazlalipour, MH Pouriayevali, T Jalali, SD Nasab, F Roohvand, Z Shoja |
Reviews in Medical Virology | 2020 |
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
D Baker, S Amor, AS Kang, K Schmierer, G Giovannoni |
Multiple Sclerosis and Related Disorders | 2020 |
Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
C Xiao, S Ling, M Qiu, Z Deng, L Chen, A Zhu, Y Chen, Y Liu, X Lin, F Lin, Q Wu, L Shen, F Ye, X Liu, Y Li, J Zhao, Z Yang, BJ Cowling, R Webby, M Zanin, SS Wong |
Influenza and Other Respiratory Viruses | 2020 |
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ES Winkler, AW Wessel, JB Case, E Kashentseva, BT McCune, AL Bailey, H Zhao, LA VanBlargan, YN Dai, M Ma, LJ Adams, S Shrihari, JE Danis, LE Gralinski, YJ Hou, A Schäfer, AS Kim, SP Keeler, D Weiskopf, RS Baric, MJ Holtzman, DH Fremont, DT Curiel, MS Diamond |
Cell | 2020 |
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
R Boudewijns, HJ Thibaut, SJ Kaptein, R Li, V Vergote, L Seldeslachts, JV Weyenbergh, CD Keyzer, L Bervoets, S Sharma, L Liesenborghs, J Ma, S Jansen, DV Looveren, T Vercruysse, X Wang, D Jochmans, E Martens, K Roose, DD Vlieger, B Schepens, TV Buyten, S Jacobs, Y Liu, J Martí-Carreras, B Vanmechelen, T Wawina-Bokalanga, L Delang, J Rocha-Pereira, L Coelmont, W Chiu, P Leyssen, E Heylen, D Schols, L Wang, L Close, J Matthijnssens, MV Ranst, V Compernolle, G Schramm, KV Laere, X Saelens, N Callewaert, G Opdenakker, P Maes, B Weynand, C Cawthorne, GV Velde, Z Wang, J Neyts, K Dallmeier |
Nature Communications | 2020 |
Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine
AH Thames, KL Wolniak, SI Stupp, MC Jewett |
ACS Central Science | 2020 |
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, S Bloor, A Ogbe, WM Zelek, A Smielewska, A Yakovleva, T Mann, L Bergamaschi, L Turner, F Mescia, EJ Toonen, CP Hackstein, HD Akther, VA Vieira, L Ceron-Gutierrez, J Periselneris, S Kiani-Alikhan, S Grigoriadou, D Vaghela, SE Lear, ME Török, WL Hamilton, J Stockton, J Quick, P Nelson, M Hunter, TI Coulter, L Devlin, JR Bradley, KG Smith, WH Ouwehand, L Estcourt, H Harvala, DJ Roberts, IB Wilkinson, N Screaton, N Loman, R Doffinger, PA Lyons, BP Morgan, IG Goodfellow, P Klenerman, PJ Lehner, NJ Matheson, JE Thaventhiran |
Nature Communications | 2020 |
Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression
J Shirazi, MJ Donzanti, KM Nelson, R Zurakowski, CA Fromen, JP Gleghorn |
Cellular and Molecular Bioengineering | 2020 |
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs
B Malone, B Simovski, C Moliné, J Cheng, M Gheorghe, H Fontenelle, I Vardaxis, S Tennøe, JA Malmberg, R Stratford, T Clancy |
Scientific Reports | 2020 |
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
M Ejemel, Q Li, S Hou, ZA Schiller, JA Tree, A Wallace, A Amcheslavsky, NK Yilmaz, KR Buttigieg, MJ Elmore, K Godwin, N Coombes, JR Toomey, R Schneider, AS Ramchetty, BJ Close, DY Chen, HL Conway, M Saeed, C Ganesa, MW Carroll, LA Cavacini, MS Klempner, CA Schiffer, Y Wang |
Nature Communications | 2020 |
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
SK Samrat, AM Tharappel, Z Li, H Li |
Virus Research | 2020 |
As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention
CR Travis |
Frontiers in immunology | 2020 |
Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications
Y Ishay, A Kessler, A Schwarts, Y Ilan |
Hepatology Communications | 2020 |
Learning from the past: development of safe and effective COVID-19 vaccines
S Su, L Du, S Jiang |
Nature Reviews Microbiology | 2020 |
On the genetics and immunopathogenesis of COVID-19
CO Jacob |
Clinical Immunology | 2020 |
Dysregulation of type I interferon responses in COVID-19
D Acharya, GQ Liu, MU Gack |
Nature Reviews Immunology | 2020 |
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink |
Journal der Deutschen Dermatologischen Gesellschaft | 2020 |
Cytokine storm induced by SARS-CoV-2
P Song, W Li, J Xie, Y Hou, C You |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial
ML Madariaga, JJ Guthmiller, S Schrantz, MO Jansen, C Christensen, M Kumar, M Prochaska, G Wool, A DurkinCelauro, WH Oh, L Trockman, J Vigneswaran, R Keskey, DG Shaw, H Dugan, NY Zheng, M Cobb, H Utset, J Wang, O Stovicek, C Bethel, S Matushek, M Giurcanu, KG Beavis, D Sabato, D Meltzer, MK Ferguson, JP Kress, K Shanmugarajah, JB Matthews, JF Fung, PC Wilson, JC Alverdy, JS Donington |
Journal of Internal Medicine | 2020 |
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID‐19
CJ Morabito, B Gangadharan |
Clinical and Translational Science | 2020 |
The role of SARS‐CoV ‐2 antibodies in COVID ‐19: Healing in most, harm at times
MA French, Y Moodley |
Respirology (Carlton, Vic.) | 2020 |
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities
MF Osuchowski, F Aletti, JM Cavaillon, SB Flohé, EJ Giamarellos-Bourboulis, M Huber-Lang, B Relja, T Skirecki, A Szabó, M Maegele |
Shock | 2020 |
ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
M Cloutier, M Nandi, AU Ihsan, HA Chamard, S Ilangumaran, S Ramanathan |
Cytokine | 2020 |
Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines
PH Lambert, DM Ambrosino, SR Andersen, RS Baric, SB Black, RT Chen, CL Dekker, AM Didierlaurent, BS Graham, SD Martin, DC Molrine, S Perlman, PA Picard-Fraser, AJ Pollard, C Qin, K Subbarao, JP Cramer |
Vaccine | 2020 |
Viral targets for vaccines against COVID-19
L Dai, GF Gao |
Nature Reviews Immunology | 2020 |
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
YS Kim, A Aigerim, U Park, Y Kim, H Park, JY Rhee, JP Choi, WB Park, SW Park, Y Kim, DG Lim, JY Choi, YK Jeon, JS Yang, JY Lee, HS Shin, NH Cho |
Clinical Infectious Diseases | 2020 |
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
M Hellerstein |
2020 | |
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
PM Varghese, AG Tsolaki, H Yasmin, A Shastri, J Ferluga, M Vatish, T Madan, U Kishore |
Immunobiology | 2020 |
Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
JA Al-Tawfiq, Y Arabi |
Human Vaccines & Immunotherapeutics | 2020 |
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
L Perico, A Benigni, F Casiraghi, LF Ng, L Renia, G Remuzzi |
Nature Reviews Nephrology | 2020 |
Severe COVID-19 and aging: are monocytes the key?
Pence BD |
GeroScience | 2020 |
ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
Rivellese F, Prediletto E |
Autoimmunity Reviews | 2020 |
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi R, Jan AT, Rahman S, Kim J |
Frontiers in Cellular and Infection Microbiology | 2020 |
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A, Obeid M, Friedlaender A |
Journal for ImmunoTherapy of Cancer | 2020 |
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
Schultheiß C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, Scholz R, Wieters I, Dahlke C, Tolosa E, Sedding DG, Ciesek S, Addo M, Binder M |
Immunity | 2020 |
Cancer and COVID-19: Unmasking their ties.
Addeo A, Friedlaender A |
Cancer Treatment Reviews | 2020 |
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
Harrison AG, Lin T, Wang P |
Trends in Immunology | 2020 |
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS |
The Journal of Infectious Diseases | 2020 |
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
Poland GA, Ovsyannikova IG, Kennedy RB |
2020 | |
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
Mudgal R, Nehul S, Tomar S |
Human Vaccines & Immunotherapeutics | 2020 |
Risiken und Chancen von Immuntherapien in Zeiten der Coronavirus-2019-Pandemie
Pawlitzki M, Zettl UK, Ruck T, Rolfes L, Hartung HP, Meuth SG |
2020 | |
High neutralizing antibody titer in intensive care unit patients with COVID-19
Liu L, To KK, Chan KH, Wong YC, Zhou R, Kwan KY, Fong CH, Chen LL, Choi CY, Lu L, Tsang OT, Leung WS, To WK, Hung IF, Yuen KY, Chen Z |
Emerging Microbes & Infections | 2020 |
Rekonvaleszentenplasma zur Behandlung von schwerem COVID-19: Rationale und Design einer randomisierten, offenen klinischen Studie von Rekonvaleszentenplasma verglichen mit bestmöglicher supportiver Behandlung (CAPSID-Studie)
Körper S, Jahrsdörfer B, Appl T, Klüter H, Seifried E, Schrezenmeier H |
2020 | |
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
Xu Z, Patel A, Tursi NJ, Zhu X, Muthumani K, Kulp DW, Weiner DB |
2020 | |
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
Zheng Y, Li R, Liu S |
Journal of Medical Virology | 2020 |
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y |
Journal of Clinical Immunology | 2020 |
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
Renn A, Fu Y, Hu X, Hall MD, Simeonov A |
Trends in Pharmacological Sciences | 2020 |
Anti-IL6R role in treatment of COVID-19-related ARDS
Buonaguro FM, Puzanov I, Ascierto PA |
Journal of Translational Medicine | 2020 |
Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia
Harapan H, Ryan M, Yohan B, Abidin RS, Nainu F, Rakib A, Jahan I, Emran TB, Ullah I, Panta K, Dhama K, Sasmono RT |
Reviews in Medical Virology | 2020 |
Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
Peron JP, Nakaya H |
Clinics | 2020 |
Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID‐19
McHugh KJ |
Bioengineering & Translational Medicine | 2020 |
Progress and Concept for COVID‐19 Vaccine Development
Wu S |
Biotechnology Journal | 2020 |
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, Zheng PY, Tian LF, Qu HQ, Liu DC, Wang EY, Xiao XJ, Li SY, Ye F, Guan L, Hu DS, Hakonarson H, Liu ZG, Zhong NS |
European Respiratory Journal | 2020 |
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development
Graepel KW, Kochhar S, Clayton EW, Edwards KE |
The Journal of Infectious Diseases | 2020 |
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato V, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ |
2020 | |
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Anderson DE, Tan CW, Chia WN, Young BE, Linster M, Low JH, Tan YJ, Chen MI, Smith GJ, Leo YS, Lye DC, Wang LF |
Emerging Microbes & Infections | 2020 |
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
Yongchen Z, Shen H, Wang X, Shi X, Li Y, Yan J, Chen Y, Gu B |
Emerging Microbes & Infections | 2020 |
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Siracusano G, Pastori C, Lopalco L |
Frontiers in immunology | 2020 |
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, Nkolola JP, Liu J, Li Z, Chandrashekar A, Martinez DR, Loos C, Atyeo C, Fischinger S, Burke JS, Slein MD, Chen Y, Zuiani A, Lelis FJ, Travers M, Habibi S, Pessaint L, Van Ry A, Blade K, Brown R, Cook A, Finneyfrock B, Dodson A, Teow E, Velasco J, Zahn R, Wegmann F, Bondzie EA, Dagotto G, Gebre MS, He X, Jacob-Dolan C, Kirilova M, Kordana N, Lin Z, Maxfield LF, Nampanya F, Nityanandam R, Ventura JD, Wan H, Cai Y, Chen B, Schmidt AG, Wesemann DR, Baric RS, Alter G, Andersen H, Lewis MG, Barouch DH |
Science (New York, N.Y.) | 2020 |
Coronaviruses pandemics: Can neutralizing antibodies help?
Tong PB, Lin LY, Tran TH |
Life Sciences | 2020 |
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
Deb B, Shah H, Goel S |
Journal of Biosciences | 2020 |
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2
Wu JL, Tseng WP, Lin CH, Lee TF, Chung MY, Huang CH, Chen SY, Hsueh PR, Chen SC |
Journal of Infection | 2020 |
Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
Yu J, Chai P, Ge S, Fan X |
Frontiers in Cell and Developmental Biology | 2020 |
Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
Ismail S, Ahmad S, Azam SS |
Journal of Molecular Liquids | 2020 |
Dengue Fever, COVID‐19 (SARS‐CoV‐2), and Antibody‐Dependent Enhancement (ADE): A Perspective
Ulrich H, Pillat MM, Tárnok A |
Cytometry Part A | 2020 |
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T |
Allergy | 2020 |
COVID-19 Diagnostics, Tools, and Prevention
Allam M, Cai S, Ganesh S, Venkatesan M, Doodhwala S, Song Z, Hu T, Kumar A, Heit J, Coskun AF |
Diagnostics | 2020 |
Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic
Levin M |
The New England journal of medicine | 2020 |
Dysregulated adaptive immune response contributes to severe COVID-19
Yu K, He J, Wu Y, Xie B, Liu X, Wei B, Zhou H, Lin B, Zuo Z, Wen W, Xu W, Zou B, Wei L, Huang X, Zhou P |
Cell Research | 2020 |
The dynamic changes of serum IgM and IgG against SARS‐CoV‐2 in patients with COVID‐19
Zhou W, Xu X, Chang Z, Wang H, Zhong X, Tong X, Liu T, Li Y |
Journal of Medical Virology | 2020 |
SARS-CoV2 vaccines: Slow is fast
Green DR |
Science Advances | 2020 |
What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist
Palatnik-de-Sousa CB |
Frontiers in immunology | 2020 |
Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?
Müller C, Schibli R, Maurer B |
Pharmaceuticals | 2020 |
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
Kurup D, Wirblich C, Ramage H, Schnell MJ |
npj Vaccines | 2020 |
Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm
Nechipurenko YD, Anashkina AA, Matveeva OV |
Biophysics | 2020 |
Coronavirus-2019 Disease (COVID-19) in Children
Ovali F |
2020 | |
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
Cardozo T, Veazey R |
International Journal of Clinical Practice | 2020 |
Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea
Kim H, Shim JY, Ko JH, Yang A, Shim JW, Kim DS, Jung HL, Kwak JH, Sol IS |
Journal of Korean Medical Science | 2020 |
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, Orner E, Sy S, Chandran K, Dziura J, Almo SC, Ring A, Keller MJ, Herold KC, Herold BC |
Science Translational Medicine | 2020 |
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
Wang S, Peng Y, Wang R, Jiao S, Wang M, Huang W, Shan C, Jiang W, Li Z, Gu C, Chen B, Hu X, Yao Y, Min J, Zhang H, Chen Y, Gao G, Tang P, Li G, Wang A, Wang L, Zhang J, Chen S, Gui X, Yuan Z, Liu D |
Nature Communications | 2020 |
Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses
Ghosh S, Malik YS |
Microorganisms | 2020 |
How to Survive COVID‐19 Even If the Vaccine Fails
Branch AD |
Hepatology Communications | 2020 |
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
Van Damme KF, Tavernier S, Van Roy N, De Leeuw E, Declercq J, Bosteels C, Maes B, De Bruyne M, Bogaert D, Bosteels V, Hoste L, Naesens L, Maes P, Grifoni A, Weiskopf D, Sette A, Depuydt P, Van Braeckel E, Haerynck F, Lambrecht BN |
Frontiers in immunology | 2020 |
Antibody responses in COVID-19 patients
Liu S, Lu S |
Journal of Biomedical Research | 2020 |
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia
Pagano G, Manfredi C, Pallardó FV, Lyakhovich A, Tiano L, Trifuoggi M |
Inflammation Research | 2020 |
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Shahrajabian MH, Sun W, Cheng Q |
Human Vaccines & Immunotherapeutics | 2020 |
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ |
Nature | 2020 |
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K |
Human Vaccines & Immunotherapeutics | 2020 |
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research
Sharun K, Tiwari R, Patel SK, Karthik K, Iqbal Yatoo M, Malik YS, Singh KP, Panwar PK, Harapan H, Singh RK, Dhama K |
Human Vaccines & Immunotherapeutics | 2020 |
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP, Choi CY, Chen LL, Chan WM, Chan KH, Ip JD, Ng AC, Poon RW, Luo CT, Cheng VC, Chan JF, Hung IF, Chen Z, Chen H, Yuen KY |
The Lancet Infectious Diseases | 2020 |
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
Zhou G, Zhao Q |
International journal of biological sciences | 2020 |
Progress and Prospects on Vaccine Development against SARS-CoV-2.
Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q |
Human vaccines | 2020 |
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
Brufsky A |
Journal of Medical Virology | 2020 |
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S |
Indian journal of ophthalmology | 2020 |
A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection.
Gómez-Rial J, Martinón-Torres F |
Clinical Immunology | 2020 |
COVID-19 diagnosis and management: a comprehensive review.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE |
Journal of Internal Medicine | 2020 |
COVID-19 Convalescent Plasma: Now Is the Time for Better Science.
Dzik S |
Transfusion Medicine Reviews | 2020 |
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
Fleming AB, Raabe V |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2020 |
COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?
Rawat M, Chandrasekharan P, Hicar MD, Lakshminrusimha S |
American journal of perinatology | 2020 |
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Nguyen AA, Habiballah SB, Platt CD, Geha RS, Chou JS, McDonald DR |
Clinical Immunology | 2020 |
The Rationale for Potential Pharmacotherapy of COVID-19.
Saber-Ayad M, Saleh MA, Abu-Gharbieh E |
Pharmaceuticals (Basel, Switzerland) | 2020 |
COVID-19 vaccines: Knowing the unknown.
Lv H, Wu NC, Mok CKP |
European Journal of Immunology | 2020 |
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
Ma C, Su S, Wang J, Wei L, Du L, Jiang S |
Microbes and Infection | 2020 |
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V, Lavelle EC |
European Journal of Immunology | 2020 |
COVID-19: are neutralizing antibodies neutralizing enough?
Kadkhoda K |
Transfusion | 2020 |
Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment.
Fallet B, Kyburz D, Walker UA |
Arthritis & Rheumatism | 2020 |
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR, Golding A, Sorbello A, Ji P, Chen J, Saluja B, Witzmann K, Arya V, Reynolds KS, Choi SY, Nikolov NP, Sahajwalla C |
Journal of clinical pharmacology | 2020 |
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.
Sironi M, Hasnain SE, Rosenthal B, Phan T, Luciani F, Shaw MA, Sallum MA, Mirhashemi ME, Morand S, González-Candelas F |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2020 |
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S |
Clinical Rheumatology | 2020 |
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M |
Journal of the American Medical Association | 2020 |
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C, Yi Y, Li J |
Virologica Sinica | 2020 |
Monoclonal antibody as a potential anti-COVID-19.
Jahanshahlu L, Rezaei N |
Biomedicine & Pharmacotherapy | 2020 |
Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.
Townsend A |
Medical Hypotheses | 2020 |
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F |
Infection and drug resistance | 2020 |
Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review.
Russo A, Minichini C, Starace M, Astorri R, Calò F, Coppola N |
Infection and drug resistance | 2020 |
Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
Begum J, Mir NA, Dev K, Buyamayum B, Wani MY, Raza M |
Transboundary and Emerging Diseases | 2020 |
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.
Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V, Papaccio M, Castellani R, Casola S, Boniotti MB, Cavadini P, Lavazza A |
EBioMedicine | 2020 |
Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India.
Natesan S, Bhatia R, Sundararajan A, Dhama K, Malik YS, Vora K |
VirusDisease | 2020 |
CT Findings in a Novel Coronavirus Disease (COVID-19) Pneumonia at Initial Presentation.
Xiang C, Lu J, Zhou J, Guan L, Yang C, Chai C |
BioMed Research International | 2020 |
[COVID-19, management, therapeutic and vaccine approaches].
Matusik É, Ayadi M, Picard N |
2020 | |
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, Li R, Liu B, Yang X, Gao L, Li Z, Lin Y, Huang Q, Xu L, Tang J, Hu L, Zhao J, Liu P, Zhang G, Chen Y, Deng K, Ye L |
Signal Transduction and Targeted Therapy | 2020 |
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
Hassanzadeh P |
Journal of Controlled Release | 2020 |
The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
Rothan HA, Byrareddy SN |
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology | 2020 |
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
Chen Y, Tong X, Li Y, Gu B, Yan J, Liu Y, Shen H, Huang R, Wu C |
PLoS pathogens | 2020 |
Antibody-dependent enhancement of coronavirus.
Wen J, Cheng Y, Ling R, Dai Y, Huang B, Huang W, Zhang S, Jiang Y |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector.
Zaichuk TA, Nechipurenko YD, Adzhubey AA, Onikienko SB, Chereshnev VA, Zainutdinov SS, Kochneva GV, Netesov SV, Matveeva OV |
Molecular Biology | 2020 |
Vaccines for COVID-19.
Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM |
Clinical & Experimental Immunology | 2020 |
Update on serologic testing in COVID-19.
Krajewski R, Gołębiowska J, Makuch S, Mazur G, Agrawal S |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
Moore JL, Ganapathiraju PV, Kurtz CP, Wainscoat B |
2020 | |
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
Liu X, Drelich A, Li W, Chen C, Sun Z, Shi M, Adams C, Mellors JW, Tseng CT, Dimitrov DS |
Vaccine | 2020 |
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
Luetkens T, Metcalf R, Planelles V, Zheng Y, Larragoite ET, Spivak ES, Spivak AM, Steinbach M, Blaylock RC, Avila SV, Hankey KG, Martins TB, Slev PR, Mannuel HD, Sajadi M, Rapoport AP, Atanackovic D |
Blood Advances | 2020 |
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Chen WH, Tao X, Agrawal AS, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CK |
Vaccine | 2020 |
A systematic review of SARS-CoV-2 vaccine candidates.
Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F |
Signal Transduction and Targeted Therapy | 2020 |
Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
Usmani SS, Raghava GPS |
Frontiers in immunology | 2020 |
Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection.
Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E |
Archives of Medical Research | 2020 |
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, Hasler S, Bosshard PP, De Cecco E, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Zinkernagel AS, Schaer DJ, Aguzzi A, Kochs G, Held U, Probst-Müller E, Rampini SK, Boyman O |
Journal of Allergy and Clinical Immunology | 2020 |
Recommendations for the Diagnosis, Prevention, and Control of Coronavirus Disease-19 in Children-The Chinese Perspectives.
Fang F, Chen Y, Zhao D, Liu T, Huang Y, Qiu L, Hao Y, Hu X, Yin W, Liu Z, Jin R, Ning Q, Cheung PT, Liu C, Shu S, Wang T, Luo X |
Frontiers in Pediatrics | 2020 |
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
To KK, Cheng VC, Cai JP, Chan KH, Chen LL, Wong LH, Choi CY, Fong CH, Ng AC, Lu L, Luo CT, Situ J, Chung TW, Wong SC, Kwan GS, Sridhar S, Chan JF, Fan CY, Chuang VWM, Kok KH, Hung IF, Yuen KY |
2020 | |
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.
Wang ZJ, Zhang HJ, Lu J, Xu KW, Peng C, Guo J, Gao XX, Wan X, Wang WH, Shan C, Zhang SC, Wu J, Yang AN, Zhu Y, Xiao A, Zhang L, Fu L, Si HR, Cai Q, Yang XL, You L, Zhou YP, Liu J, Pang DQ, Jin WP, Zhang XY, Meng SL, Sun YX, Desselberger U, Wang JZ, Li XG, Duan K, Li CG, Xu M, Shi ZL, Yuan ZM, Yang XM, Shen S |
Emerging Microbes & Infections | 2020 |
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Ortiz-Prado E, Simbaña-Rivera K, Gómez- Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AM, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A |
Diagnostic Microbiology and Infectious Disease | 2020 |
Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
Scala S, Pacelli R |
Frontiers in immunology | 2020 |
A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease
Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K |
International Journal of Infectious Diseases | 2020 |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
Banerjee A, Santra D, Maiti S |
Journal of Translational Medicine | 2020 |
Immune-mediated approaches against COVID-19
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R |
Nature Nanotechnology | 2020 |
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M |
Life Sciences | 2020 |
SARS-CoV-2-specific ELISA development
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G |
Journal of Immunological Methods | 2020 |
SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
Chen W, Zhang J, Qin X, Wang W, Xu M, Wang LF, Xu C, Tang S, Liu P, Zhang L, Liu X, Zhang Y, Yi C, Hu Z, Yi Y |
Biomedicine & Pharmacotherapy | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AV, Lambe T, Gilbert SC, Pollard AJ |
2020 | |
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Luban J, Sattler RA, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, Pykett M, Welch EM, O\u2019Keefe K, Kong R, Goodwin E, Jacobson A, Paessler S, Peltz SW |
Virus Research | 2020 |
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung JY, Thone MN, Kwon YJ |
Advanced Drug Delivery Reviews | 2020 |
A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine
Hörner C, Schürmann C, Auste A, Ebenig A, Muraleedharan S, Dinnon KH III, Scholz T, Herrmann M, Schnierle BS, Baric RS, Mühlebach MD |
Proceedings of the National Academy of Sciences | 2020 |
RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
Sandbrink JB, Shattock RJ |
Frontiers in immunology | 2020 |
Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Mannino F, Bitto A, Irrera N |
Frontiers in pharmacology | 2020 |
Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
Suzuki Y, Tanino Y, Nikaido T, Minemura H, Umeda T, Rikimaru M, Onuma T, Naito S, Takiguchi Y, Tomita H, Kawamata T, Togawa R, Sato Y, Uematsu M, Morimoto J, Kitakawa K, Tsukada Y, Nakamura K, Kanemitsu K, Iseki K, Shibata Y |
Internal Medicine | 2020 |
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams ER, Ainsworth M, Anand R, Andersson MI, Auckland K, Baillie JK, Barnes E, Beer S, Bell JI, Berry T, Bibi S, Carroll M, Chinnakannan SK, Clutterbuck E, Cornall RJ, Crook DW, de Silva T, Dejnirattisai W, Dingle KE, Dold C, Espinosa A, Eyre DW, Farmer H, Fernandez Mendoza M, Georgiou D, Hoosdally SJ, Hunter A, Jefferey K, Kelly DF, Klenerman P, Knight J, Knowles C, Kwok AJ, Leuschner U, Levin R, Liu C, López-Camacho C, Martinez J, Matthews PC, McGivern H, Mentzer AJ, Milton J, Mongkolsapaya J, Moore SC, Oliveira MS, Pereira F, Perez E, Peto T, Ploeg RJ, Pollard A, Prince T, Roberts DJ, Rudkin JK, Sanchez V, Screaton GR, Semple MG, Slon-Campos J, Skelly DT, Smith EN, Sobrinodiaz A, Staves J, Stuart DI, Supasa P, Surik T, Thraves H, Tsang P, Turtle L, Walker AS, Wang B, Washington C, Watkins N, Whitehouse J |
Wellcome Open Research | 2020 |
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses
Kim KD, Hwang I, Ku\u2020 KB, Lee S, Kim SJ, Kim C |
Journal of Microbiology and Biotechnology | 2020 |
Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?
Collins AM, Yaari G, Shepherd AJ, Lees W, Watson CT |
Current Opinion in Systems Biology | 2020 |
Convalescent Plasma in COVID-19
Banwait RS, Salabei JK, Fishman TJ, Iyer UG |
2020 | |
[Progress and analysis on the development of 2019-nCoV vaccine].
Kang Z, Tang M |
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi | 2020 |
Establishment of an African green monkey model for COVID-19
Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, Melody K, Geisbert JB, Fenton KA, Geisbert TW, Cross RW |
2020 | |
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement
Chen WH, Tao X, Agrawal A, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CT |
2020 | |
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Faustini SE, Jossi SE, Perez-Toledo M, Shields AM, Allen JD, Watanabe Y, Newby ML, Cook A, Willcox CR, Salim M, Goodall M, Heaney JL, Marcial-Juarez E, Morley GL, Torlinska B, Wraith DC, Veenith TV, Harding S, Jolles S, Ponsford MJ, Plant T, Huissoon A, O\u2019Shea MK, Willcox BE, Drayson MT, Crispin M, Cunningham AF, Richter AG |
2020 | |
COVID-19 neutralizing antibodies predict disease severity and survival
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB |
2020 | |
Severe Acute Respiratory Syndrome
DS Hui, A Zumla |
Infectious Disease Clinics of North America | 2019 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |